protocol_name,last_updated,author,clinical_indications,patient_positioning,npo_status,premedication_notes,contrast_agent,contrast_volume,contrast_flow_rate,contrast_timing_method,contrast_roi_placement,contrast_trigger_hu,contrast_labs_notes,tech_notes,nursing_notes,radiologist_notes,gantt_contrast_volume,gantt_contrast_duration,gantt_saline_volume,gantt_saline_duration,gantt_scan_section,gantt_scan_phase,gantt_scan_style,gantt_scan_delay,gantt_scan_duration,safety_renal_function,safety_allergy_check,series_1_name,series_1_start,series_1_end,series_1_delay,series_1_thickness,series_1_notes,series_2_name,series_2_start,series_2_end,series_2_delay,series_2_thickness,series_2_notes,series_3_name,series_3_start,series_3_end,series_3_delay,series_3_thickness,series_3_notes,series_4_name,series_4_start,series_4_end,series_4_delay,series_4_thickness,series_4_notes,series_5_name,series_5_start,series_5_end,series_5_delay,series_5_thickness,series_5_notes,postproc_1_plane,postproc_1_acq,postproc_1_fov,postproc_1_thickness,postproc_1_kernel,postproc_1_ir,postproc_1_notes,postproc_2_plane,postproc_2_acq,postproc_2_fov,postproc_2_thickness,postproc_2_kernel,postproc_2_ir,postproc_2_notes,postproc_3_plane,postproc_3_acq,postproc_3_fov,postproc_3_thickness,postproc_3_kernel,postproc_3_ir,postproc_3_notes,postproc_4_plane,postproc_4_acq,postproc_4_fov,postproc_4_thickness,postproc_4_kernel,postproc_4_ir,postproc_4_notes,artifact_reduction_tip,category,kv,mas,rotation_time,pitch,additional_recons,
CT Pulmonary Embolism,2026-01-01,,Suspected pulmonary embolism | Acute dyspnea | Chest pain with elevated D-dimer,Supine feet-first with arms raised,NPO 2 hours recommended,None required,Isovue 370,100 mL,4-5 mL/s,Bolus Tracking,Main Pulmonary Artery,150 HU,Full dose if eGFR > 30. Reduce if eGFR 30-60,Caudocranial scan direction. Coach breath hold. ROI in main PA at level of bifurcation,20G or larger IV in antecubital preferred. Verify good flow before injection,Assess RV/LV ratio. Look for signs of right heart strain. Check for DVT in leg veins if imaged,100mL,25s,50mL,13s,Chest,Pulmonary arterial phase,crit,0:20,12s,Verify eGFR > 30,Check iodine allergy history and prior reactions,Scout/Topogram,Lung apices,Adrenal glands,N/A,N/A,AP and lateral,Pulmonary Angiogram,Lung apices,Adrenal glands,Bolus tracked,0.625 mm,Caudocranial direction from diaphragm to apices,,,,,,,,,,,,,,,,,,,Axial,Angiogram,Chest,1.25 mm/1.25 mm,Standard,3,Mediastinal window for PE assessment,Axial,Angiogram,Chest,2.5 mm/2.5 mm,Lung,3,Lung window for parenchymal assessment,Coronal,Angiogram,Chest,3 mm/3 mm,Standard,3,Overview of pulmonary vasculature,Sagittal,Angiogram,Chest,3 mm/3 mm,Standard,3,Optional for clinical correlation,Arms fully raised to reduce beam hardening,chest,100,Auto (reference 200),0.5,1.0-1.2,MIP reconstructions of pulmonary arteries,
CT Abdomen Pelvis with Contrast,2026-01-02,,Abdominal pain | Oncology staging | Infection source | Post-operative complications,Supine with arms raised,NPO 4 hours for solids,Oral contrast: 900 mL Readi-Cat 2 over 90 minutes. Last cup 30 min before scan,Omnipaque 350,125 mL,3 mL/s,Fixed delay,N/A,N/A,Full dose if eGFR > 30. Consider split bolus technique if eGFR 30-45,Ensure adequate oral contrast opacification. Scan from diaphragm through pubic symphysis. 70 second delay typical,18-20G IV required. Verify patent IV. May give rectal contrast for distal colon/rectal evaluation. Oral contrast 900mL given 2 hrs before,Systematic review of all solid organs. Check for free fluid/air. Assess bowel enhancement pattern,125mL,42s,50mL,17s,Abdomen/Pelvis,Portal venous phase,done,1:10,25s,Verify eGFR > 30,Check allergy history. Pre-medicate if prior reaction,Scout/Topogram,Diaphragm,Pubic symphysis,N/A,N/A,AP and lateral,Portal Venous Phase,Diaphragm,Pubic symphysis,70 sec,0.625 mm,Standard portal venous timing,,,,,,,,,,,,,,,,,,,Axial,Portal venous,Abdomen,3 mm/3 mm,Standard,3,Primary diagnostic series,Axial,Portal venous,Pelvis,3 mm/3 mm,Standard,3,Pelvis diagnostic series,Coronal,Portal venous,Full AP,3 mm/3 mm,Standard,3,Coronal reformats for overview,Sagittal,Portal venous,Full AP,3 mm/3 mm,Standard,3,Sagittal reformats for bowel loops,Arms raised completely. Remove all metal objects from scan range,abdomen,120,Auto (reference 200),0.5,1.0-1.375,Thin slice 1mm for 3D if mass identified,
Non-Contrast CT Head,2026-01-03,,Acute stroke protocol | Head trauma | Headache - worst of life | Altered mental status,Supine head-first,None,None,None,None,None,None,N/A,N/A,No contrast required,Minimize patient motion. Gantry angle parallel to skull base to reduce orbital dose. Ensure head straight,No IV required. Explain importance of staying still,Look for hyperdense MCA sign. Assess grey-white differentiation. Check for hemorrhage and mass effect,N/A,N/A,N/A,N/A,Head,Non-contrast scan,done,0:00,10s,N/A,N/A,Scout/Topogram,Vertex,C1,N/A,N/A,Lateral scout,Non-Contrast Head,Vertex,Foramen magnum,N/A,5 mm,Angle parallel to hard palate,,,,,,,,,,,,,,,,,,,Axial,Non-contrast,Brain,5 mm/5 mm,Brain,3,Primary diagnostic - brain window,Axial,Non-contrast,Brain,5 mm/5 mm,Bone,N/A,Bone window for fractures,Coronal,Non-contrast,Brain,3 mm/3 mm,Brain,3,Optional - for skull base evaluation,Sagittal,Non-contrast,Brain,3 mm/3 mm,Brain,3,Optional - for midline structures,Remove dentures and hearing aids. Secure head in holder,neuro,120,Auto (reference 300),1,0.5,Thin slice 1.25mm if subtle fracture suspected,
CTA Head and Neck (Arch to Vertex),2026-01-04,,Stroke workup | Carotid stenosis | Vertebral artery dissection | Aneurysm screening,Supine head-first with arms at sides,NPO 2 hours,None typically. Consider anxiolytic if severe claustrophobia,Isovue 370,80-100 mL,4-5 mL/s,Bolus Tracking,Aortic arch,150 HU,Full dose if eGFR > 30,Scan from aortic arch through vertex. Use bolus tracking in arch. Minimize dental artifact with gantry angulation,Good antecubital IV access required - 20G minimum. Verify injection site for extravasation risk,Evaluate complete circle of Willis. Assess carotid bifurcations. Look for dissection. Check aneurysms,90mL,20s,40mL,10s,Head/Neck,Arterial phase,crit,0:22,25s,Verify eGFR > 30,Check allergy history and renal function,Scout/Topogram,Aortic arch,Vertex,N/A,N/A,AP and lateral,CTA Neck,Aortic arch,Skull base,Bolus tracked,0.625 mm,Arterial phase - caudocranial,CTA Head,Skull base,Vertex,Continues from neck,0.625 mm,Same bolus as neck - single acquisition,,,,,,,,,,,,,Axial,CTA,Neck,1 mm/1 mm,Vascular,3,Submillimeter for carotid assessment,Axial,CTA,Head,1 mm/1 mm,Vascular,3,Submillimeter for circle of Willis,Coronal,CTA,Neck,2 mm/2 mm,Vascular,3,MIP for carotid overview,Sagittal,CTA,Full,2 mm/2 mm,Vascular,3,MIP for vertebral arteries,Remove dentures. Minimize swallowing during neck acquisition,vascular,100-120,Auto (reference 250),0.5,0.9,MIP and 3D VR reconstructions of vessels. Curved MPR of carotids,
CTA for GI Bleed,2026-01-05,,Active GI bleeding | Hematemesis | Melena with hemodynamic instability | Hematochezia,Supine with arms raised,NPO if possible (emergent study),None,Isovue 370,125 mL,5 mL/s,Triple phase: Arterial + Portal Venous + Delayed,Abdominal aorta,150 HU,Can proceed with eGFR > 30 in emergency. Document medical necessity,High flow rate critical for arterial phase. Scan arterial at 25 sec then portal at 70 sec then delayed at 90-180 sec. Look for active extravasation,Large bore IV 18-20G essential. Must achieve 5 mL/s flow rate. Verify with saline test,Look for arterial extravasation (early) and pooling (delayed). Note location and potential source vessel,125mL,25s,50mL,10s,Abdomen/Pelvis,Arterial phase,crit,0:25,15s,eGFR > 30 preferred but can proceed emergently,Document allergy history. Emergency indication overrides mild allergy,Scout/Topogram,Diaphragm,Pubic symphysis,N/A,N/A,AP scout,Arterial Phase,Diaphragm,Pubic symphysis,25 sec,0.625 mm,High flow rate 5 mL/s critical,Portal Venous Phase,Diaphragm,Pubic symphysis,70 sec,0.625 mm,Standard portal venous timing,Delayed Phase,Diaphragm,Pubic symphysis,90-180 sec,0.625 mm,Extended delay to see pooling of contrast,,,,,,,Axial,Arterial,Full AP,2.5 mm/2.5 mm,Standard,3,Look for arterial blush/extravasation,Axial,Portal venous,Full AP,2.5 mm/2.5 mm,Standard,3,Confirm bleeding and assess organs,Axial,Delayed,Full AP,2.5 mm/2.5 mm,Standard,3,Look for contrast pooling in bowel,Coronal,All phases,Full AP,3 mm/3 mm,Standard,3,MIP to track extravasation,Arms raised to avoid artifacts. Fast table speed to cover area quickly in arterial phase,vascular,100-120,Auto (reference 300),0.5,1.375,MIP of all three phases side-by-side for comparison,
CTA Chest Abdomen Pelvis,2024-01-15,Dr. Smith,Aortic dissection | Aortic aneurysm | Vasculitis | Trauma pan-scan,Supine with arms raised above head,NPO 2-4 hours,None,Isovue 370,125 mL,4 mL/s,Bolus Tracking,Descending thoracic aorta,150 HU,Full dose if eGFR > 30,Single acquisition from thoracic inlet to pubic symphysis. Caudocranial direction. Bolus track in descending aorta,20G IV minimum. Antecubital or proximal forearm preferred,Assess entire aorta for dissection/aneurysm. Measure aortic dimensions. Check branch vessels,125mL,31s,50mL,13s,Full Body,Arterial phase,crit,0:28,35s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Thoracic inlet,Pubic symphysis,N/A,N/A,AP and lateral,CTA Arterial,Thoracic inlet,Pubic symphysis,Bolus tracked,0.625 mm,Caudocranial from feet to head,,,,,,,,,,,,,,,,,,,Axial,Arterial,Chest,2 mm/2 mm,Vascular,3,Thoracic aorta evaluation,Axial,Arterial,Abdomen/Pelvis,2.5 mm/2.5 mm,Vascular,3,Abdominal aorta and branches,Coronal,Arterial,Full CAP,3 mm/3 mm,Vascular,3,MIP full aorta overview,Sagittal,Arterial,Full CAP,3 mm/3 mm,Vascular,3,Sagittal MIP and curved MPR of aorta,Arms completely raised. ECG monitoring if known dissection,vascular,100,Auto (reference 250),0.5,1.0-1.2,3D VR and curved MPR of entire aorta,
CTA Chest,2024-01-15,Dr. Johnson,Thoracic aortic aneurysm | Aortic dissection | Great vessel evaluation,Supine with arms raised,NPO 2 hours,None,Isovue 370,100 mL,4 mL/s,Bolus Tracking,Ascending aorta or main PA,150 HU,Full dose if eGFR > 30,Choose ROI based on indication - ascending aorta for aortic pathology or main PA for PE,20G IV minimum,Assess aorta and great vessels. Measure aneurysm if present. Look for dissection flap,100mL,25s,50mL,13s,Chest,Arterial phase,crit,0:25,15s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Lung apices,Adrenal glands,N/A,N/A,AP and lateral,CTA Arterial Chest,Lung apices,Adrenal glands,Bolus tracked,0.625 mm,Caudocranial direction,,,,,,,,,,,,,,,,,,,Axial,Arterial,Chest,1.25 mm/1.25 mm,Vascular,3,Primary diagnostic series,Axial,Arterial,Chest,2.5 mm/2.5 mm,Lung,3,Lung window for parenchyma,Coronal,Arterial,Chest,2.5 mm/2.5 mm,Vascular,3,MIP coronal great vessels,Sagittal,Arterial,Chest,2.5 mm/2.5 mm,Vascular,3,MIP sagittal aortic arch,Arms fully raised,vascular,100,Auto (reference 200),0.5,1.0-1.2,3D VR of thoracic vasculature,
CTA Abdomen Pelvis,2024-01-15,Dr. Martinez,Abdominal aortic aneurysm | Mesenteric ischemia | Renal artery stenosis | Pre-EVAR planning,Supine with arms raised,NPO 4 hours,Oral contrast optional - omit for vascular indication,Isovue 370,125 mL,4 mL/s,Bolus Tracking,Abdominal aorta at celiac,150 HU,Full dose if eGFR > 30. Critical for renal artery assessment,Caudocranial scan direction. Include renal arteries to femoral bifurcation minimum,18-20G IV antecubital,Measure AAA if present. Assess renal and mesenteric arteries. Evaluate iliac vessels,125mL,31s,50mL,13s,Abdomen/Pelvis,Arterial phase,crit,0:30,25s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Diaphragm,Femoral heads,N/A,N/A,AP lateral,CTA Arterial,Diaphragm,Femoral heads,Bolus tracked,0.625 mm,Caudocranial direction,,,,,,,,,,,,,,,,,,,Axial,Arterial,Abdomen,2 mm/2 mm,Vascular,3,Abdominal aorta and visceral branches,Axial,Arterial,Pelvis,2.5 mm/2.5 mm,Vascular,3,Iliac vessels,Coronal,Arterial,Full AP,3 mm/3 mm,Vascular,3,MIP coronal aorta and branches,Sagittal,Arterial,Full AP,3 mm/3 mm,Vascular,3,Curved MPR of aorta,Arms raised. No oral contrast for pure vascular study,vascular,100,Auto (reference 250),0.5,1.0-1.375,3D VR and curved MPR. Measure AAA in 3 planes,
CTA Mesenteric Ischemia,2024-01-15,Dr. Lee,Acute mesenteric ischemia | Chronic mesenteric ischemia | Bowel infarction,Supine with arms raised,NPO (emergent - as patient presents),None - emergent study,Isovue 370,125 mL,5 mL/s,Dual phase: Arterial + Portal Venous,Abdominal aorta at celiac,150 HU,Proceed if eGFR > 30. Emergency indication in acute setting,Arterial phase at 25 sec for vessel assessment. Portal venous at 70 sec for bowel perfusion. High flow rate critical,18G IV required for 5 mL/s flow. Must be patent,Arterial: assess celiac SMA IMA origins. Portal: look for bowel wall enhancement. Check for pneumatosis,125mL,25s,50mL,10s,Mesenteric,Arterial phase,crit,0:25,20s,eGFR > 30 preferred,Emergency study - document indication,Scout/Topogram,Diaphragm,Pubic symphysis,N/A,N/A,AP,Arterial Phase,Diaphragm,Iliac crests,25 sec,0.625 mm,Focus on celiac SMA IMA,Portal Venous,Diaphragm,Pubic symphysis,70 sec,0.625 mm,Assess bowel wall enhancement,,,,,,,,,,,,,Axial,Arterial,Abdomen,2 mm/2 mm,Vascular,3,Mesenteric vessel origins,Axial,Portal venous,Full AP,2.5 mm/2.5 mm,Standard,3,Bowel wall assessment,Coronal,Arterial,Abdomen,2.5 mm/2.5 mm,Vascular,3,MIP of mesenteric vessels,Sagittal,Arterial,Abdomen,2.5 mm/2.5 mm,Vascular,3,Curved MPR SMA from origin,Fast scan. High flow rate essential,vascular,100,Auto (reference 300),0.5,1.375,MIP and 3D VR of celiac and SMA. Curved MPR of vessels,
CTA DIEP Flap Pre-operative,2024-01-15,Dr. Williams,Pre-operative planning for DIEP flap breast reconstruction,Supine with arms at sides or on chest,NPO 2-4 hours,None,Isovue 370,100 mL,4 mL/s,Bolus Tracking,Abdominal aorta,150 HU,Full dose if eGFR > 30,Scan from xiphoid to pubic symphysis. Focus on anterior abdominal wall perforators. Arterial phase critical,18-20G IV,Map perforator locations. Measure vessel caliber. Identify dominant perforators. Note relationship to rectus,100mL,25s,50mL,13s,Abdomen,Arterial phase,crit,0:28,15s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Xiphoid,Pubic symphysis,N/A,N/A,AP,CTA Arterial,Xiphoid,Pubic symphysis,Bolus tracked,0.625 mm,Focus on abdominal wall,,,,,,,,,,,,,,,,,,,Axial,Arterial,Abdomen,1 mm/1 mm,Vascular,3,Thin slice for perforator mapping,Coronal,Arterial,Abdomen,1.5 mm/1.5 mm,Vascular,3,MIP to show perforator course,Sagittal,Arterial,Abdomen,2 mm/2 mm,Vascular,3,Lateral views of perforators,3D VR,Arterial,Anterior abd wall,1 mm source,Vascular,3,3D reconstruction for surgical planning,Arms positioned to not obscure anterior abdominal wall,vascular,100,Auto (reference 200),0.5,0.9,3D VR color-coded perforator map. Measure distances from umbilicus,
CTA Upper Extremity,2024-01-15,Dr. Davis,Upper extremity arterial insufficiency | Trauma | Dialysis access planning | Thoracic outlet syndrome,Supine with affected arm raised above head or at side depending on indication,NPO 2 hours,None,Isovue 370,100 mL,4 mL/s,Bolus Tracking,Subclavian artery,150 HU,Full dose if eGFR > 30,Scan from aortic arch to fingertips. May need bilateral for comparison. Position arm to demonstrate pathology,20G IV in contralateral arm,Assess subclavian axillary brachial radial ulnar arteries. Look for stenosis occlusion or injury,100mL,25s,40mL,10s,Upper Extremity,Arterial phase,crit,0:25,20s,Verify eGFR > 30,Check allergy history. IV in opposite arm,Scout/Topogram,Aortic arch,Fingertips,N/A,N/A,AP of arm,CTA Arterial,Aortic arch,Fingertips,Bolus tracked,0.625 mm,Include arch through hand,,,,,,,,,,,,,,,,,,,Axial,Arterial,Full arm,1.5 mm/1.5 mm,Vascular,3,Primary diagnostic,Coronal,Arterial,Full arm,2 mm/2 mm,Vascular,3,MIP full vessel course,Sagittal,Arterial,Full arm,2 mm/2 mm,Vascular,3,Lateral MIP,3D VR,Arterial,Full arm,1 mm source,Vascular,3,3D reconstruction,Position arm to avoid overlap with torso. May need special positioning for TOS,vascular,100,Auto (reference 200),0.5,0.9,MIP and 3D VR. Subtract bones for vessel visualization,
CTA Lower Extremity Runoff for PAD,2024-01-15,Dr. Anderson,Peripheral arterial disease | Claudication | Critical limb ischemia | Pre-operative bypass planning,Supine with arms raised. Legs straight,NPO 2-4 hours,None,Isovue 370,150 mL,4 mL/s,Bolus Tracking,Abdominal aorta,150 HU,Full dose if eGFR > 30. May need larger volume for slow flow,Scan from renal arteries to feet. Use automatic bolus tracking. Extend delay if known severe PAD. Cover tibial vessels to ankle,18-20G IV antecubital,Assess aortoiliac femoral popliteal and tibial vessels. Grade stenoses. Identify occlusions. Assess runoff vessels,150mL,38s,50mL,13s,Lower Extremity,Arterial phase,crit,0:35,45s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Renal arteries,Feet,N/A,N/A,AP full legs,CTA Arterial,Renal arteries,Ankle,Bolus tracked,0.625 mm,May need slower table speed if severe PAD,,,,,,,,,,,,,,,,,,,Axial,Arterial,Pelvis/Legs,2 mm/2 mm,Vascular,3,Assess all vessel segments,Coronal,Arterial,Full legs,3 mm/3 mm,Vascular,3,MIP full arterial tree,Sagittal,Arterial,Full legs,3 mm/3 mm,Vascular,3,Lateral views of vessels,3D VR,Arterial,Full legs,1.5 mm source,Vascular,3,3D for surgical planning,Ensure legs are straight and not rotated. Remove shoes and metal,vascular,100-120,Auto (reference 250),0.5,1.2-1.5,MIP and 3D VR. Curved MPR of each arterial segment. Bone subtraction for vessels.,
CTA Popliteal Entrapment,2024-01-15,Dr. Thompson,Popliteal entrapment syndrome | Exercise-induced leg pain | Young patient with claudication,Supine with legs extended in neutral position,NPO 2-4 hours,None,Isovue 370,100 mL,4 mL/s,Dual position: Neutral + Plantarflexion,Popliteal artery,150 HU,Full dose if eGFR > 30,TWO acquisitions required: 1) Neutral position 2) Active plantarflexion. Both legs scanned for comparison. Coach patient on plantarflexion technique,18-20G IV antecubital,Compare neutral vs plantarflexion images. Look for popliteal artery compression deviation or occlusion with plantarflexion. Assess muscle anatomy,100mL,25s,50mL,13s,Lower Legs,Arterial phase,crit,0:28,15s,Verify eGFR > 30,Check allergy history. Explain plantarflexion maneuver to patient,Scout/Topogram,Distal femur,Ankle,N/A,N/A,AP both legs,CTA Neutral Position,Distal femur,Ankle,Bolus tracked,0.625 mm,Both legs neutral resting position,CTA Plantarflexion,Distal femur,Ankle,Immediately after,0.625 mm,Patient actively plantarflexes both feet - point toes,,,,,,,,,,,,,Axial,Neutral,Both legs,1.5 mm/1.5 mm,Vascular,3,Baseline popliteal artery anatomy,Axial,Plantarflexion,Both legs,1.5 mm/1.5 mm,Vascular,3,Assess for compression with maneuver,Coronal,Both phases,Both legs,2 mm/2 mm,Vascular,3,MIP comparison neutral vs flexion,Sagittal,Both phases,Both legs,2 mm/2 mm,Vascular,3,Lateral view popliteal fossa,Coach patient on maintaining plantarflexion during second acquisition. Use foot straps if needed,vascular,100,Auto (reference 200),0.5,0.9,Side-by-side comparison of neutral vs plantarflexion. 3D VR showing muscle-vessel relationship,
CTA Lower Extremity Free Flap,2024-01-15,Dr. Kim,Pre-operative planning for free flap harvest (fibula ALT anterolateral thigh),Supine with legs extended,NPO 2-4 hours,None,Isovue 370,120 mL,4 mL/s,Bolus Tracking,Femoral artery,150 HU,Full dose if eGFR > 30,Scan from iliac crest to ankle. Focus on perforators in region of interest. Arterial phase critical for mapping,18-20G IV,Map perforator vessels. Measure vessel caliber and length. Identify dominant pedicle. Note anatomic variants,120mL,30s,50mL,13s,Lower Extremity,Arterial phase,crit,0:30,25s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Iliac crest,Ankle,N/A,N/A,AP both legs for comparison,CTA Arterial,Iliac crest,Ankle,Bolus tracked,0.625 mm,Bilateral for comparison and variants,,,,,,,,,,,,,,,,,,,Axial,Arterial,Thighs/Legs,1 mm/1 mm,Vascular,3,Thin slice for perforator identification,Coronal,Arterial,Full legs,1.5 mm/1.5 mm,Vascular,3,MIP to show perforator course,Sagittal,Arterial,Full legs,2 mm/2 mm,Vascular,3,Lateral perforator views,3D VR,Arterial,Region of interest,0.75 mm source,Vascular,3,Color-coded perforator map for surgery,Legs straight and not rotated. Mark skin over region of interest if possible,vascular,100,Auto (reference 200),0.5,0.9,3D VR perforator map. Curved MPR of main vessels. Measure perforator locations from bony landmarks,
CTA Pelvis Cyclist Iliac Artery Maneuver,2024-01-15,Dr. Rodriguez,External iliac artery endofibrosis | Cyclist with exercise-induced leg symptoms,Supine initially then with hip flexion,NPO 2-4 hours,None,Isovue 370,100 mL,4 mL/s,Dual position: Resting + Hip flexion cycling position,External iliac artery,150 HU,Full dose if eGFR > 30,TWO acquisitions: 1) Resting supine 2) Hip flexion simulating cycling position. Bilateral imaging for comparison,18-20G IV,Compare resting vs flexed position. Look for iliac artery kinking stenosis or occlusion with hip flexion. Common in competitive cyclists,100mL,25s,50mL,13s,Pelvis,Arterial phase,crit,0:28,12s,Verify eGFR > 30,Check allergy history. Explain hip flexion positioning,Scout/Topogram,L3,Proximal femur,N/A,N/A,AP pelvis,CTA Resting Position,L3,Mid femur,Bolus tracked,0.625 mm,Supine resting position,CTA Hip Flexion,L3,Mid femur,Immediately after,0.625 mm,Hips flexed 90 degrees - cycling position,,,,,,,,,,,,,Axial,Resting,Pelvis,1.5 mm/1.5 mm,Vascular,3,Baseline iliac artery anatomy,Axial,Flexion,Pelvis,1.5 mm/1.5 mm,Vascular,3,Assess for kinking with flexion,Coronal,Both phases,Pelvis,2 mm/2 mm,Vascular,3,MIP comparison rest vs flexion,Sagittal,Both phases,Pelvis,2 mm/2 mm,Vascular,3,Lateral view iliac course,Position patient with knees bent and hips flexed to simulate cycling. May need positioning aids,vascular,100,Auto (reference 200),0.5,0.9,Side-by-side MIP of rest vs flexion. Measure degree of stenosis. 3D VR,
CTA Pelvis Prostate Artery Embolization,2024-01-15,Dr. Jackson,Pre-procedural planning for prostate artery embolization | Benign prostatic hyperplasia,Supine with arms raised,NPO 2-4 hours,None,Isovue 370,100 mL,3-4 mL/s,Bolus Tracking,Common iliac artery,150 HU,Full dose if eGFR > 30,Scan from L3 to proximal femur. Arterial phase essential. Focus on internal iliac branches and prostate supply,18-20G IV,Identify prostate artery origins (usually anterior division of internal iliac). Map anatomy for IR. Note variants and anastomoses,100mL,28s,50mL,14s,Pelvis,Arterial phase,crit,0:30,10s,Verify eGFR > 30,Check allergy history,Scout/Topogram,L3,Proximal femur,N/A,N/A,AP pelvis,CTA Arterial,L3,Proximal femur,Bolus tracked,0.625 mm,Focus on internal iliac branches,,,,,,,,,,,,,,,,,,,Axial,Arterial,Pelvis,1 mm/1 mm,Vascular,3,Identify prostate artery origins,Coronal,Arterial,Pelvis,1.5 mm/1.5 mm,Vascular,3,MIP of iliac vessels,Sagittal,Arterial,Pelvis,1.5 mm/1.5 mm,Vascular,3,Lateral view pelvic vessels,3D VR,Arterial,Pelvis,0.75 mm source,Vascular,3,3D roadmap for interventional radiologist,Full bladder helpful for prostate visualization. Coordinate with IR before scan,vascular,100,Auto (reference 200),0.5,0.9,3D VR with prostate vessels highlighted. Curved MPR of internal iliac branches. Measure vessel diameters,
CTV Abdomen Pelvis,2024-01-15,Dr. Chen,Deep vein thrombosis | May-Thurner syndrome | IVC filter placement planning | Venous malformation,Supine with arms raised,NPO 2-4 hours,Oral contrast optional,Isovue 370,125 mL,3 mL/s,Fixed delay - Venous phase,N/A,N/A,Full dose if eGFR > 30,Scan at 180 seconds for venous phase. Slower injection rate OK for venous imaging. Scan from diaphragm to femoral veins,18-20G IV,Assess IVC iliac femoral veins for thrombosis. Look for compression (May-Thurner). Measure vessel caliber for filter sizing,125mL,42s,50mL,17s,Abdomen/Pelvis,Venous phase,done,3:00,25s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Diaphragm,Proximal femur,N/A,N/A,AP,CTV Venous Phase,Diaphragm,Proximal femur,180 sec,0.625 mm,Extended delay for venous opacification,,,,,,,,,,,,,,,,,,,Axial,Venous,Full AP,2.5 mm/2.5 mm,Standard,3,Assess for filling defects,Coronal,Venous,Full AP,3 mm/3 mm,Standard,3,MIP of venous system,Sagittal,Venous,Full AP,3 mm/3 mm,Standard,3,IVC and iliac veins,3D VR,Venous,Full AP,2 mm source,Standard,3,3D venous anatomy,Arms raised. May add leg veins if DVT suspected,vascular,120,Auto (reference 200),0.5,1.0-1.375,MIP venograms. 3D VR of venous system,
CTV Chest Abdomen Pelvis,2024-01-15,Dr. White,Superior vena cava syndrome | Central venous occlusion | Tumor staging with venous involvement,Supine with arms raised,NPO 2-4 hours,None,Isovue 370,125 mL,3 mL/s,Fixed delay - Venous phase,N/A,N/A,Full dose if eGFR > 30,Scan at 180 seconds. Include SVC through femoral veins. May need arm injection for SVC assessment,18-20G IV - may need bilateral arm IVs for SVC,Assess SVC IVC and major tributaries. Look for thrombosis compression or tumor invasion,125mL,42s,50mL,17s,Full Body,Venous phase,done,3:00,35s,Verify eGFR > 30,Check allergy history. May need bilateral IVs,Scout/Topogram,Thoracic inlet,Proximal femur,N/A,N/A,AP full body,CTV Venous Phase,Thoracic inlet,Proximal femur,180 sec,0.625 mm,Extended venous phase,,,,,,,,,,,,,,,,,,,Axial,Venous,Chest,2 mm/2 mm,Standard,3,SVC and central veins,Axial,Venous,Abdomen/Pelvis,2.5 mm/2.5 mm,Standard,3,IVC and tributaries,Coronal,Venous,Full CAP,3 mm/3 mm,Standard,3,MIP full venous system,Sagittal,Venous,Full CAP,3 mm/3 mm,Standard,3,Sagittal venogram,Arms raised. For SVC consider bilateral arm injection,vascular,120,Auto (reference 200),0.5,1.0-1.2,3D venogram MIP. Curved MPR of SVC and IVC,
CTA SCAD/FMD Protocol,2024-01-15,Dr. Hayes,Spontaneous coronary artery dissection screening | Fibromuscular dysplasia screening | Multi-vessel arterial assessment,Supine with arms initially UP then DOWN,NPO 4 hours,None,Isovue 370,150 mL total,4 mL/s,Multi-phase: NC Head + CTA Neck + CTA CAP arms up + Post-contrast Head arms down,Multiple ROIs,150 HU,Full dose if eGFR > 30. Large volume for multiple phases,FOUR acquisitions: 1) NC Head arms down 2) CTA Neck bolus track 3) CTA CAP arms up 4) Post Head arms down. Patient repositions arms between scans,20G IV minimum. Verify good flow for multiple phases,Screen all vascular beds for FMD. Look for beading stenosis aneurysm dissection. Assess renal carotid vertebral intracranial arteries,150mL,38s,50mL,13s,Multi-territory,Multi-phase arterial,crit,Variable,60s total,Verify eGFR > 30,Check allergy history. Explain arm repositioning,Non-contrast Head,Vertex,Foramen magnum,N/A,5 mm,Arms down - baseline,CTA Neck,Aortic arch,Vertex,Bolus tracked,0.625 mm,Arms down - carotid/vertebral,CTA CAP,Diaphragm,Pubic symphysis,35 sec after neck,0.625 mm,Arms UP - renal and mesenteric,Post-contrast Head,Vertex,Foramen magnum,After CAP,1.25 mm,Arms DOWN - intracranial vessels,,,,,,,Axial,All phases,Respective FOV,Phase-specific,Vascular,3,Comprehensive arterial assessment,Coronal,CTA phases,Full body,2-3 mm/2-3 mm,Vascular,3,MIP of all arterial territories,Sagittal,CTA phases,Full body,2-3 mm/2-3 mm,Vascular,3,Lateral views all vessels,3D VR,CTA phases,Full body,1 mm source,Vascular,3,3D reconstruction multi-territory,Coach patient on arm repositioning. Multiple phases require good IV. Plan scan sequence carefully,vascular,100-120,Auto (reference 200-250),0.5,0.9-1.2,Comprehensive MIP and 3D VR of all vascular beds. Measure vessel diameters. Document FMD findings,
Calcium Score,2024-01-15,Dr. Smith,Cardiovascular risk assessment | Chest pain low-intermediate risk | Asymptomatic screening,Supine feet-first,NPO not required,HR control not needed for calcium score,None,None,None,Prospective gating,N/A,N/A,No contrast required,Prospective ECG gating. 3mm slices. Cover entire heart. 75% R-R interval typical. Ensure ECG leads well connected,No IV needed. Apply ECG leads carefully. Explain breath hold,Calculate Agatston score. Report percentile for age/sex. Document coronary calcification distribution,N/A,N/A,N/A,N/A,Heart,Non-contrast scan,done,0:00,5s,N/A,N/A,Scout,Top of chest,Diaphragm,N/A,N/A,AP and lateral,Calcium Score,Carina,Below heart,Prospective 75%,3 mm,Sequential axial gated acquisition,,,,,,,,,,,,,,,,,,,Axial,Calcium score,Heart,3 mm/3 mm,Standard,3,For Agatston score calculation,Axial,Calcium score,Heart,3 mm/3 mm,Standard,3,Duplicate for quality control,Curved MPR,Calcium score,Coronaries,3 mm,Standard,3,Optional vessel-specific views,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Good ECG tracing essential. Patient breath hold coaching,cardiac,120,Auto (low dose),0.28-0.35,Sequential,Agatston score calculation. Percentile reporting,
Coronary CTA Post-CABG,2024-01-15,Dr. Johnson,Post-CABG graft patency assessment | Recurrent chest pain post-bypass,Supine feet-first,NPO 2-4 hours,HR < 60 target. Metoprolol 5mg IV increments up to 15mg. Nitro 0.4mg SL before scan,Isovue 370,1.1-1.3 mL/kg,4-5 mL/s,Bolus Tracking,Ascending aorta,200 HU,Full dose if eGFR > 30,Retrospective gating for CABG. FULL CHEST FOV to include grafts. Extended coverage from thoracic inlet to below heart. Pitch 0.2-0.24,20G IV minimum. HR control critical - target < 60. Nitro administration,Assess all grafts: LIMA RIMA SVG. Check anastomoses. Native vessel disease. Graft patency vs occlusion,90mL,20s,30mL,7s,Chest,Arterial gated,crit,0:25,15s,Verify eGFR > 30,Check metoprolol contraindications. BP > 100 required,Scout,Thoracic inlet,Below heart,N/A,N/A,AP lateral,Non-contrast,Top of heart,Below heart,N/A,3 mm,Calcium score,Gated CTA,Thoracic inlet,Below heart,Bolus tracked,0.5-0.625 mm,Retrospective gating - full chest FOV,,,,,,,,,,,,,Axial,Gated CTA,Full chest,0.75 mm/0.5 mm,Cardiac,3,Thin slice for grafts and native vessels,Curved MPR,Gated CTA,Each graft,0.75 mm,Cardiac,3,Individual graft reconstructions,Axial,Gated CTA,Heart,0.75 mm/0.5 mm,Cardiac,3,Native coronary assessment,3D VR,Gated CTA,Heart/grafts,0.5 mm source,Cardiac,3,3D overview grafts and native vessels,Full chest coverage essential. Extended FOV. Low pitch for retrospective gating,cardiac,100-120,Auto ECG modulation,0.28,0.2-0.24,Curved MPR of all grafts. Label LIMA RIMA SVG. 3D VR color-coded,
Coronary CTA,2024-01-15,Dr. Johnson,Intermediate chest pain | Suspected infarct | Coronary artery dissection or aneurysm | Anomalous coronary artery | Stent patency,Supine feet-first,NPO 2-4 hours,HR < 60 target. Metoprolol 5mg IV increments up to 15mg. Nitro 0.4mg SL before scan,Isovue 370,1.1-1.3 mL/kg,4-5 mL/s,Bolus Tracking,Ascending aorta,200 HU,Full dose if eGFR > 30,Retrospective ECG gating. 3mm slices. Cover entire heart. 75% R-R interval typical. Ensure ECG leads well connected,20G IV minimum. HR control critical - target < 60. Nitro administration,Calculate Agatston score. Give CAD-RADS score. Check function look for potential focal wall motion abnormalities,90mL,20s,30mL,7s,Heart,Arterial gated,crit,0:25,15s,Verify eGFR > 30,Check metoprolol contraindications. BP > 100 required,Scout,Thoracic inlet,Below heart,N/A,N/A,AP lateral,Non-contrast,Top of heart,Below heart,N/A,3 mm,Calcium score,Gated CTA,Top of heart,Below heart,Bolus tracked,0.5-0.625 mm,Retrospective gating ,,,,,,,,,,,,,Axial,Gated CTA,Heart,0.75 mm/0.5 mm,Cardiac,3,Thin slice for grafts and native vessels,Curved MPR,Gated CTA,Heart,0.75 mm,Cardiac,3,Vessels,Axial,Gated CTA,Heart,0.75 mm/0.5 mm,Cardiac,3,Native coronary assessment,3D VR,Gated CTA,Heart/grafts,0.5 mm source,Cardiac,3,3D overview grafts and native vessels,Full chest coverage essential. Extended FOV. Low pitch for retrospective gating,cardiac,100-120,Auto ECG modulation,0.28,0.2-0.24,Curved MPR of all grafts. Label LIMA RIMA SVG. 3D VR color-coded,
Endocarditis/Cardiac Mass,2024-01-15,Dr. Martinez,Endocarditis | Cardiac mass | Valve vegetation | Intracardiac thrombus,Supine feet-first,NPO 2-4 hours,HR < 65 preferred. Metoprolol if needed. Nitro not typically needed,Isovue 370,1.1 mL/kg,4-5 mL/s,Bolus Tracking,Ascending aorta,200 HU,Full dose if eGFR > 30,Retrospective gating. Cover entire heart. Focus on valves and chambers. May need delayed phase for perfusion,20G IV. HR control helpful but not critical,Assess all valves for vegetations. Evaluate myocardium for abscess. Look for intracardiac masses. Check for complications,80mL,18s,30mL,7s,Heart,Arterial gated,crit,0:23,10s,Verify eGFR > 30,Check allergy history,Scout,Top of chest,Diaphragm,N/A,N/A,AP lateral,Gated CTA,Top of heart,Below heart,Bolus tracked,0.5-0.625 mm,Retrospective ECG gating,Delayed phase,Top of heart,Below heart,180 sec,2 mm,Optional for perfusion assessment,,,,,,,,,,,,,Axial,Gated CTA,Heart,0.75 mm/0.5 mm,Cardiac,3,Valve and chamber assessment,Axial,Gated CTA,Heart,0.75 mm/0.5 mm,Cardiac,3,Reformatted at multiple phases,Short axis,Gated CTA,Heart,2 mm,Cardiac,3,Valve en face views,Long axis,Gated CTA,Heart,2 mm,Cardiac,3,Chamber and valve evaluation,Multiple cardiac phases helpful for valve motion. Thin slices for vegetations,cardiac,100-120,Auto ECG modulation,0.28,0.2-0.24,Multi-phase reconstructions. 4-chamber 2-chamber views. Valve-specific reformats,
Gated CTA CAP,2024-01-15,Dr. Lee,Aortic dissection | Aortic aneurysm with cardiac involvement | Combined cardiac and aortic pathology,Supine with arms raised,NPO 2-4 hours,HR < 65 target. Metoprolol 5mg IV prn. Nitro 0.4mg SL,Isovue 370,140 mL,4 mL/s,Dual phase: Gated chest + Flash AP,Ascending aorta,180 HU,Full dose if eGFR > 30. Large volume needed,TWO acquisitions: 1) Gated retrospective CHEST 2) Flash helical ABDOMEN/PELVIS. Chest gated for aortic root. AP flash arterial,20G IV minimum,Gated chest: assess aortic root valve coronaries. Flash AP: assess aorta and branches. Combined cardiac and vascular,140mL,35s,50mL,13s,Combined,Gated chest + Flash AP,crit,Variable,40s,Verify eGFR > 30,Check allergy history,Scout,Thoracic inlet,Pubic symphysis,N/A,N/A,Full AP lateral,Gated CTA Chest,Thoracic inlet,Diaphragm,Bolus tracked,0.5-0.625 mm,Retrospective gating chest,Flash CTA AP,Diaphragm,Pubic symphysis,Immediate after chest,0.625 mm,High pitch helical - no gating,,,,,,,,,,,,,Axial,Gated chest,Chest,0.75 mm/0.75 mm,Cardiac,3,Aortic root and valve,Axial,Flash AP,Abdomen/Pelvis,2 mm/2 mm,Vascular,3,Abdominal aorta and branches,Coronal,Both,Full CAP,2.5 mm/2.5 mm,Vascular,3,MIP full aorta,Sagittal,Both,Full CAP,2.5 mm/2.5 mm,Vascular,3,Curved MPR entire aorta,Arms up. Careful timing between gated and flash acquisitions,cardiac,100,Auto ECG chest / High mAs AP,0.28 chest / 0.5 AP,0.2-0.24 chest / 1.2-1.5 AP,Curved MPR full aorta. Aortic valve reformats. 3D VR,
Gated CTA CAP Sternotomy Revision,2024-01-15,Dr. Williams,Pre-operative planning for redo sternotomy | Retrosternal structures assessment,Supine with arms raised,NPO 4 hours,HR < 65. Metoprolol IV prn. Nitro 0.4mg SL,Isovue 370,150 mL,4 mL/s,Triple phase: Gated chest + AP arterial + Chest venous,Ascending aorta,180 HU,Full dose if eGFR > 30. Large volume protocol,THREE acquisitions: 1) Gated CHEST 2) Flash AP arterial 3) CHEST venogram 60 sec delay. Venous for retrosternal structures,20G IV,Gated: cardiac anatomy. Arterial: systemic vessels. VENOUS: retrosternal veins and adherent structures critical for surgical planning,150mL,38s,50mL,13s,Multi-phase,Gated + Arterial + Venous,crit,Variable,50s,Verify eGFR > 30,Large contrast load - verify renal function,Scout,Thoracic inlet,Pubic symphysis,N/A,N/A,AP lateral full,Gated CTA Chest,Thoracic inlet,Diaphragm,Bolus tracked,0.5-0.625 mm,Retrospective gating,Flash AP,Diaphragm,Pubic symphysis,After gated,0.625 mm,Arterial phase AP,Venogram Chest,Thoracic inlet,Diaphragm,60 sec,1 mm,Retrosternal venous structures,,,,,,,Axial,Gated chest,Chest,0.75 mm/0.75 mm,Cardiac,3,Cardiac and coronary anatomy,Axial,Venogram,Chest,1.25 mm/1.25 mm,Standard,3,Critical for retrosternal structures,Coronal,All phases,Chest,2 mm/2 mm,Standard,3,Anterior chest wall structures,3D VR,Venogram,Chest,1 mm source,Standard,3,3D map retrosternal vessels for surgery,Venous phase critical for surgical planning. Map all retrosternal structures,cardiac,100,Auto ECG chest / High mAs other,0.28 / 0.5,0.2-0.24 / 1.2-1.5,3D VR venogram highlighting retrosternal veins. Distance measurements sternum to heart,
Gated CTA TAVR,2024-01-15,Dr. Davis,Pre-TAVR planning | Aortic stenosis valve replacement planning,Supine with arms raised,NPO 4 hours,HR < 65 target. Metoprolol IV. Nitro 0.4mg SL,Isovue 370,140 mL,4 mL/s,Dual phase: Gated chest + Flash AP,Ascending aorta,180 HU,Full dose if eGFR > 30,Gated CHEST retrospective + Flash AP. Gated for valve measurements. AP for access planning. TAVR post-processing required,20G IV antecubital,Measure aortic annulus (3 diameters). Coronary heights. Access vessels (iliofemoral). Valve calcium. Comprehensive TAVR measurements,140mL,35s,50mL,13s,TAVR,Gated chest + Flash AP,crit,Variable,40s,Verify eGFR > 30,Check allergy history,Scout,Thoracic inlet,Femoral heads,N/A,N/A,AP lateral full,Gated CTA Chest,Thoracic inlet,Diaphragm,Bolus tracked,0.5 mm,Retrospective gating for valve,Flash CTA AP,Diaphragm,Femoral heads,After gated,0.625 mm,Iliofemoral access planning,,,,,,,,,,,,,Axial,Gated chest,Heart,0.5 mm/0.5 mm,Cardiac,3,Aortic valve and root measurements,Axial,Flash AP,AP,2 mm/2 mm,Vascular,3,Access vessel assessment,Double oblique,Gated chest,Aortic valve,0.5 mm,Cardiac,3,En face aortic annulus for sizing,3D VR,Flash AP,Iliofemoral,1.5 mm source,Vascular,3,3D access planning,TAVR-specific measurements protocol. Thin slices critical,cardiac,100,Auto ECG chest / High mAs AP,0.28 / 0.5,0.2-0.24 / 1.2-1.5,TAVR measurements: annulus area perimeter diameters. Coronary heights. Sinus of Valsalva. STJ. Ascending aorta. Access vessels,
Gated CTA Chest,2024-01-15,Dr. Anderson,Coronary artery disease | Chest pain | Anomalous coronaries | Coronary CTA,Supine feet-first,NPO 2-4 hours,HR < 60 target. Metoprolol 5mg IV up to 15mg total. Nitro 0.4mg SL. Check BP > 100,Isovue 370,1.1 mL/kg,4-5 mL/s,Bolus Tracking,Ascending aorta,200 HU,Full dose if eGFR > 30,Retrospective ECG gating. Cover heart. Bolus tracking in ascending aorta. Optional stent protocol: add 40 sec delayed phase,20G IV minimum. HR control critical. Nitro administration. Monitor BP,Assess coronaries for stenosis plaque. Evaluate anomalous anatomy. Stent patency if applicable. Cardiac function from multi-phase,80mL,18s,30mL,7s,Heart,Coronary arterial,crit,0:23,8s,Verify eGFR > 30,Check metoprolol contraindications,Scout,Top of chest,Diaphragm,N/A,N/A,AP lateral,Non-contrast,Top of heart,Below heart,N/A,3 mm,Calcium score,Gated CTA,Top of heart,Below heart,Bolus tracked,0.5-0.625 mm,Retrospective ECG gating,Stent delay (optional),Top of heart,Below heart,40 sec,0.5-0.625 mm,Optional for stent assessment,,,,,,,Axial,Gated CTA,Heart,0.75 mm/0.5 mm,Cardiac,3,Primary coronary assessment,Curved MPR,Gated CTA,Each coronary,0.75 mm,Cardiac,3,Vessel-specific reconstructions,Axial,Non-contrast,Heart,3 mm/3 mm,Standard,3,Calcium scoring,Short/long axis,Gated CTA,Heart,Multi-phase,Cardiac,3,Functional assessment,HR control essential. Coach breathing. Gating quality check,cardiac,100,Auto ECG modulation,0.28,0.2-0.24,Curved MPR all coronaries. Short/long axis. Multi-phase for function. Calcium score,
Gated CTA Chest Post-op Cardiac Valve,2024-01-15,Dr. Thompson,Post-operative valve assessment | Prosthetic valve evaluation | Post-surgical complications,Supine feet-first,NPO 2-4 hours,HR < 65 preferred. Metoprolol if needed,Isovue 370,1.3 mL/kg,4-5 mL/s,Bolus Tracking,Ascending aorta,200 HU,Full dose if eGFR > 30. Increased volume for metal artifact,Retrospective gating. INCREASED kV to 130-140 for metal artifact reduction. Increased contrast 1.3 mL/kg. Extended reconstruction phases,20G IV minimum,Assess prosthetic valve function. Look for paravalvular leak. Evaluate perivalvular complications. Metal artifact reduction critical,95mL,21s,30mL,7s,Heart,Arterial gated,crit,0:25,10s,Verify eGFR > 30,Check allergy history,Scout,Top of chest,Diaphragm,N/A,N/A,AP lateral,Gated CTA,Top of heart,Below heart,Bolus tracked,0.5-0.625 mm,Retrospective gating HIGH kV,,,,,,,,,,,,,,,,,,,Axial,Gated CTA,Heart,0.75 mm/0.75 mm,Cardiac,3,Prosthetic valve assessment,Axial,Gated CTA,Heart,Multi-phase,Cardiac,3,Multiple cardiac phases for motion,Short axis,Gated CTA,Valve level,1 mm,Cardiac,3,En face valve views,Long axis,Gated CTA,Heart,Multi-phase,Cardiac,3,Valve motion assessment,High kV (130-140) critical for metal artifact. Increased contrast volume,cardiac,130-140,Auto ECG modulation,0.28,0.2-0.24,Multi-phase reconstructions. Valve-specific views. Paravalvular assessment,
Gated CTA Heart Left Atrial Mapping,2024-01-15,Dr. Kim,Pre-ablation planning | Atrial fibrillation | Pulmonary vein anatomy,Supine feet-first,NPO 2-4 hours,HR < 65 preferred. Metoprolol if needed. Nitro not typically required,Isovue 370,1.1 mL/kg,4-5 mL/s,Bolus Tracking,Ascending aorta,200 HU,Full dose if eGFR > 30,Retrospective gating. Focus on left atrium and pulmonary veins. Thin slices critical. Extended coverage for all PV ostia,20G IV,Map pulmonary vein anatomy (number ostia diameters). Left atrial appendage morphology. Esophageal position. LA size,80mL,18s,30mL,7s,Heart,Arterial gated,crit,0:23,8s,Verify eGFR > 30,Check allergy history,Scout,Top of chest,Below heart,N/A,N/A,AP lateral,Gated CTA,Pulmonary veins,Below LA,Bolus tracked,0.5 mm,Retrospective - thin slices critical,,,,,,,,,,,,,,,,,,,Axial,Gated CTA,LA/PV,0.5 mm/0.5 mm,Cardiac,3,Primary PV anatomy,Coronal,Gated CTA,LA/PV,0.75 mm,Cardiac,3,PV ostia en face,Sagittal,Gated CTA,LA/PV,0.75 mm,Cardiac,3,Lateral PV views,3D VR,Gated CTA,LA/PV,0.5 mm source,Cardiac,3,3D LA and PV reconstruction for EP,Thin slices essential. Complete PV coverage. Document variants,cardiac,100,Auto ECG modulation,0.28,0.2-0.24,3D LA reconstruction. PV ostia measurements (diameter area). LAA morphology. Esophageal position,
Gated CTA TMVR,2024-01-15,Dr. Rodriguez,Pre-TMVR planning | Mitral valve replacement planning | Mitral regurgitation,Supine with arms raised,NPO 4 hours,HR < 65. Metoprolol IV prn,Omnipaque 350,140 mL,4 mL/s,Dual phase: Gated chest NO dose modulation + 90 sec delayed CAP,Ascending aorta,180 HU,Full dose if eGFR > 30,Gated CHEST with NO DOSE PULSING (full dose all phases) + delayed 90 sec CAP. TMVR post-processing required,20G IV,Measure mitral annulus. LA size. LVOT assessment. Coronary proximity. Access vessels. TMVR-specific measurements,140mL,35s,50mL,13s,TMVR,Gated chest + Delayed CAP,crit,Variable,45s,Verify eGFR > 30,Check allergy history,Scout,Thoracic inlet,Femoral heads,N/A,N/A,AP lateral,Gated CTA Chest,Top of heart,Below heart,Bolus tracked,0.5 mm,NO DOSE PULSING - retrospective all phases,Delayed CAP,Diaphragm,Femoral heads,90 sec,0.625 mm,Access planning and coronaries,,,,,,,,,,,,,Axial,Gated chest,Heart,0.5 mm/0.5 mm,Cardiac,3,Mitral valve measurements,Axial,Delayed CAP,AP,2 mm/2 mm,Vascular,3,Access vessels,Double oblique,Gated chest,Mitral valve,0.5 mm,Cardiac,3,En face mitral annulus,3D VR,Delayed CAP,Iliofemoral,1.5 mm,Vascular,3,Access planning,NO dose modulation for gated chest. Full radiation all phases for valve assessment,cardiac,100,NO ECG MODULATION chest / Auto AP,0.28 / 0.5,0.2-0.24 / 1.2-1.5,TMVR measurements: annulus dimensions. LVOT area. Coronary heights. LA volume. Access vessels,
Gated CTA TTVR,2024-01-15,Dr. Jackson,Pre-TTVR planning | Tricuspid valve replacement planning | Tricuspid regurgitation,Supine with arms raised,NPO 4 hours,HR < 65. Metoprolol IV prn,Omnipaque 350,140 mL,4 mL/s,Dual phase: Gated chest NO dose modulation + 90 sec delayed CAP,Ascending aorta,180 HU,Full dose if eGFR > 30,Gated CHEST with NO DOSE PULSING + delayed 90 sec CAP. TTVR post-processing required,20G IV,Measure tricuspid annulus. RA size. RV function. Coronary proximity. Access vessels. TTVR-specific measurements,140mL,35s,50mL,13s,TTVR,Gated chest + Delayed CAP,crit,Variable,45s,Verify eGFR > 30,Check allergy history,Scout,Thoracic inlet,Femoral heads,N/A,N/A,AP lateral,Gated CTA Chest,Top of heart,Below heart,Bolus tracked,0.5 mm,NO DOSE PULSING - all phases,Delayed CAP,Diaphragm,Femoral heads,90 sec,0.625 mm,Access planning,,,,,,,,,,,,,Axial,Gated chest,Heart,0.5 mm/0.5 mm,Cardiac,3,Tricuspid valve measurements,Axial,Delayed CAP,AP,2 mm/2 mm,Vascular,3,Access assessment,Double oblique,Gated chest,Tricuspid valve,0.5 mm,Cardiac,3,En face tricuspid annulus,3D VR,Delayed CAP,Iliofemoral,1.5 mm,Vascular,3,Access planning,NO dose modulation. Full dose all cardiac phases,cardiac,100,NO ECG MODULATION chest / Auto AP,0.28 / 0.5,0.2-0.24 / 1.2-1.5,TTVR measurements: annulus dimensions area perimeter. RA volume. RV function. Coronary proximity. Access vessels,
CT Chest Abdomen Pelvis with Contrast,2024-01-15,Dr. Smith,Oncology staging | Infection source | Abdominal pain | Trauma,Supine with arms raised,NPO 4 hours solids. Clear liquids OK up to 2 hours,Oral contrast: 250-500 mL neutral (Volumen or water). Give 60-90 min before scan,Omnipaque 350,1.5 mL/kg,3-4 mL/s,Fixed delay 70 seconds,N/A,N/A,Full dose if eGFR > 30. High volume protocol,Single phase portal venous. Oral contrast for bowel opacification. 40 second injection. 70 second scan delay from start of injection,18-20G IV. Adequate oral contrast intake. Verify renal function,Portal venous phase optimal for solid organ and bowel assessment. Systematic review all organs,150mL (70kg),40s,50mL,13s,CAP,Portal venous phase,done,1:10,30s,Verify eGFR > 30,Check allergy history,Scout/Topogram,Thoracic inlet,Pubic symphysis,N/A,N/A,AP and lateral,Portal Venous Phase,Lung bases or diaphragm,Pubic symphysis,70 sec,0.625 mm,Single portal venous phase,,,,,,,,,,,,,,,,,,,Axial,Portal venous,Chest,2.5 mm/2.5 mm,Standard,3,Chest diagnostic,Axial,Portal venous,Abdomen,2.5 mm/2.5 mm,Standard,3,Abdomen diagnostic,Axial,Portal venous,Pelvis,3 mm/3 mm,Standard,3,Pelvis diagnostic,Coronal,Portal venous,Full CAP,3 mm/3 mm,Standard,3,Coronal overview,Arms fully raised. Neutral oral contrast preferred over positive,abdomen,120,Auto (reference 200),0.5,1.0-1.375,Sagittal reformats optional,
CT KUB Non-Contrast,2024-01-15,Dr. Johnson,Nephrolithiasis | Renal colic | Flank pain | Hematuria,Supine with arms raised,None required,None,None,None,None,Non-contrast,N/A,N/A,No contrast. No oral contrast,LOW DOSE protocol. Reduced mAs. Cover kidneys to pubic symphysis. Stone protocol settings,No IV needed. No oral contrast. Explain low radiation technique,Look for stones - measure size and location. Check for hydronephrosis. Assess for alternative diagnoses,N/A,N/A,N/A,N/A,Abdomen/Pelvis,Non-contrast scan,done,0:00,15s,N/A,N/A,Scout,Top of kidneys,Pubic symphysis,N/A,N/A,AP scout,Non-Contrast KUB,Top of kidneys,Pubic symphysis,N/A,1-2 mm,Low dose technique,,,,,,,,,,,,,,,,,,,Axial,Non-contrast,KUB,2.5 mm/2.5 mm,Standard,3,Stone detection,Axial,Non-contrast,KUB,2.5 mm/2.5 mm,Bone,N/A,Bone window for stones,Coronal,Non-contrast,KUB,3 mm/3 mm,Standard,3,Coronal stone overview,MIP,Non-contrast,Kidneys/ureters,5 mm slab,Standard,N/A,Stone localization,Low dose protocol. Reduced mAs. Image quality adequate for stones,abdomen,100-120,Low dose (50-100 ref),0.5,1.375-1.5,Thin slice 1mm for small stones. Stone size measurements,
CT Enterography,2024-01-15,Dr. Martinez,Crohn disease | Small bowel obstruction | Obscure GI bleeding | Small bowel mass,Supine with arms raised,NPO 4 hours solids,Neutral oral contrast (VoLumen): 1st bottle (450mL) at 90 min. 2nd bottle (450mL) at 60 min. Half bottle (225mL) at 30 min. Other half (225mL) at 5 min before scan,Omnipaque 350,1.5 mL/kg,4-5 mL/s,Fixed delay 45 seconds,N/A,N/A,Full dose if eGFR > 30. High flow rate,Enterographic phase (45 sec). High volume neutral oral for bowel distension. 25 second injection. Scan 45 sec from start,18-20G IV. Ensure adequate oral contrast intake (total ~1350mL). May need anti-peristaltic agent,Assess bowel wall enhancement and thickness. Look for strictures fistulas abscesses. Mesenteric vascularity,150mL (70kg),25s,50mL,10s,Abdomen/Pelvis,Enteric phase,done,0:45,20s,Verify eGFR > 30,Check allergy history. Coordinate oral contrast timing,Scout,Diaphragm,Pubic symphysis,N/A,N/A,AP,Enteric Phase,Diaphragm,Pubic symphysis,45 sec,0.625 mm,Optimal small bowel enhancement,,,,,,,,,,,,,,,,,,,Axial,Enteric,Full AP,2.5 mm/2.5 mm,Standard,3,Primary diagnostic,Coronal,Enteric,Full AP,3 mm/3 mm,Standard,3,Bowel loop assessment,Sagittal,Enteric,Full AP,3 mm/3 mm,Standard,3,Mesenteric evaluation,MIP,Enteric,Mesenteric vessels,5 mm slab,Vascular,3,Vascular assessment,Adequate oral contrast distension critical. High injection rate,abdomen,100,Auto (reference 200),0.5,1.0-1.375,Curved MPR of bowel segments. Mesenteric vascular assessment,
CT Triple Phase Liver,2024-01-15,Dr. Lee,Liver lesion characterization | HCC surveillance | Liver mass protocol,Supine with arms raised,NPO 4 hours,None typically. Oral contrast optional,Omnipaque 350,1.5 mL/kg,4-5 mL/s,Triple phase: NC + Arterial + Portal Venous + Delayed,Abdominal aorta,150 HU,Full dose if eGFR > 30,FOUR acquisitions: 1) NC abdomen 2) Late arterial (bolus track or 30-35s) 3) Portal venous 70s 4) Delayed 5 min. FOV: Abdomen for NC/Art/Delay. Full AP for PV,18-20G IV. High flow rate critical,NC: characterize lesion. Arterial: hypervascular lesions HCC. Portal: most liver lesions. Delayed: washout pattern,150mL (70kg),32s,50mL,11s,Liver,Triple phase,crit,Variable,Multiple,Verify eGFR > 30,Check allergy history,Scout,Diaphragm,Iliac crests,N/A,N/A,AP,Non-Contrast,Diaphragm,Iliac crests,N/A,2.5 mm,Liver FOV,Late Arterial,Diaphragm,Iliac crests,30-35 sec or bolus track,1.25 mm,Liver FOV - hypervascular lesions,Portal Venous,Diaphragm,Pubic symphysis,70 sec,2.5 mm,Full AP FOV,Delayed Phase,Diaphragm,Iliac crests,5 min (300 sec),2.5 mm,Liver FOV - washout assessment,Axial,All phases,Liver,2.5 mm/2.5 mm,Standard,3,Compare all phases,Axial,Portal venous,Full AP,2.5 mm/2.5 mm,Standard,3,Full abdomen pelvis PV,Coronal,All phases,Liver,3 mm/3 mm,Standard,3,Coronal comparison,Subtraction,Arterial - NC,Liver,2.5 mm,Standard,3,Enhance lesion conspicuity,High flow rate. Extended 5 min delay. Breath hold coaching,abdomen,100,Auto (reference 200-250),0.5,0.9-1.0,,
CT Biphasic Pancreas,2024-01-15,Dr. Williams,Pancreatic mass | Pancreatitis | Pancreatic cyst characterization,Supine with arms raised,NPO 4 hours,Water PO: 900 mL water orally 15-30 min before scan for gastric/duodenal distension,Omnipaque 350,1.5 mL/kg,4-5 mL/s,Dual phase: Pancreatic arterial + Portal venous,Abdominal aorta,150 HU,Full dose if eGFR > 30,TWO phases: Pancreatic phase (40-45s or bolus track) + Portal venous (70s). Water for negative contrast,18-20G IV. Ensure water intake for duodenal distension,Pancreatic phase: optimal pancreatic enhancement and small lesions. Portal venous: liver and venous structures,150mL (70kg),32s,50mL,11s,Pancreas,Pancreatic + Portal phases,crit,0:40,Multiple,Verify eGFR > 30,Check allergy history. Coordinate water intake,Scout,Diaphragm,Iliac crests,N/A,N/A,AP,Pancreatic Phase,Diaphragm,Iliac crests,40-45 sec or bolus track,1-1.25 mm,Thin slices for small lesions,Portal Venous,Diaphragm,Iliac crests,70 sec,2.5 mm,Standard PV phase,,,,,,,,,,,,,Axial,Pancreatic,Pancreas,1.5 mm/1.5 mm,Standard,3,Thin slice pancreas,Axial,Portal venous,Abdomen,2.5 mm/2.5 mm,Standard,3,Liver and vessels,Coronal,Both phases,Abdomen,2.5 mm/2.5 mm,Standard,3,Pancreatic and peripancreatic,Curved MPR,Pancreatic,Pancreatic duct,1.5 mm,Standard,3,Duct evaluation,Water distension of duodenum helpful. Thin slices for pancreas,abdomen,100,Auto (reference 200-250),0.5,0.9-1.0,Curved MPR pancreatic duct. MIP pancreatic vasculature,
CT Renal Mass Protocol,2024-01-15,Dr. Davis,Renal mass characterization | Renal cell carcinoma staging | Complex cyst evaluation,Supine with arms raised,NPO 4 hours,None,Omnipaque 350,Split bolus: 1st injection 1.1 mL/kg + 2nd injection 0.4 mL/kg,4 mL/s,Split bolus technique,Abdominal aorta for 1st,150 HU,Full dose if eGFR > 30. Split bolus technique,COMPLEX protocol: 1) NC 2) 1st contrast injection 3) Arterial 20s after 1st 4) WAIT 5-7 min 5) 2nd injection + saline 6) IVP/nephrographic 90-120s after 2nd,18-20G IV. Explain split bolus technique and delay,NC: fat/calcification. Arterial: vascular anatomy and hypervascular masses. Nephrographic/IVP: delayed enhancement and collecting system,110mL + 40mL (70kg),23s + 10s,50mL,13s,Kidneys,Multi-phase renal,crit,Variable,Multiple,Verify eGFR > 30,Check allergy history,Scout,Diaphragm,Iliac crests,N/A,N/A,AP,Non-Contrast,Top kidneys,Iliac crests,N/A,2.5 mm,Baseline - detect fat/calcium,Corticomedullary,Top kidneys,Iliac crests,20 sec after 1st injection,1.25 mm,Arterial/nephrographic,Nephrographic/IVP,Top kidneys,Pubic symphysis,90-120 sec after 2nd injection,1.25 mm,Delayed enhancement + collecting system,,,,,,,Axial,Non-contrast,Kidneys,2.5 mm/2.5 mm,Standard,3,Characterize mass,Axial,Corticomedullary,Kidneys,1.5 mm/1.5 mm,Standard,3,Vascular and cortical enhancement,Axial,Nephrographic,Kidneys to pelvis,2 mm/2 mm,Standard,3,Mass enhancement + urinary opacification,Coronal,All phases,Kidneys,2.5 mm/2.5 mm,Standard,3,Compare enhancement phases,Split bolus timing critical. 5-7 min wait between injections,abdomen,100-120,Auto (reference 200),0.5,1,Compare NC vs arterial vs nephrographic. Measure HU in mass. MIP urogram,
CT IVP (Intravenous Pyelogram),2024-01-15,Dr. Anderson,Hematuria | Urothelial carcinoma | Collecting system evaluation | Hydronephrosis,Supine with arms raised,NPO 4 hours,None,Omnipaque 350,Split bolus: 1st injection 1.1 mL/kg + 2nd injection 0.4 mL/kg,4 mL/s,Split bolus technique,Abdominal aorta,150 HU,Full dose if eGFR > 30. Split bolus for combined nephrographic and excretory phases,COMPLEX protocol: 1) NC (optional stone protocol) 2) 1st contrast injection 3) Early PV 60s after 1st 4) WAIT 5-7 min 5) 2nd injection + saline 6) Excretory/IVP 90-120s after 2nd,18-20G IV. Split bolus technique. May give Lasix 10-20mg IV for better opacification,NC optional: detect stones. Early PV: renal parenchyma. Excretory: collecting system ureters bladder for urothelial lesions,110mL + 40mL (70kg),23s + 10s,50mL,13s,Urinary tract,Multi-phase IVP,done,Variable,Multiple,Verify eGFR > 30,Check allergy history,Scout,Top kidneys,Pubic symphysis,N/A,N/A,AP,Non-Contrast (optional),Top kidneys,Pubic symphysis,N/A,2 mm,Optional stone detection,Early Portal Venous,Top kidneys,Iliac crests,60 sec after 1st,2.5 mm,Nephrographic phase,Excretory Phase,Top kidneys,Pubic symphysis,90-120 sec after 2nd,1.25 mm,Collecting system opacification,,,,,,,Axial,Non-contrast,KUB,2 mm/2 mm,Standard,3,Stone detection if done,Axial,Portal venous,Kidneys,2.5 mm/2.5 mm,Standard,3,Renal parenchyma,Axial,Excretory,Full urinary tract,2 mm/2 mm,Standard,3,Urothelial surfaces,Coronal,Excretory,Full urinary tract,2.5 mm/2.5 mm,Standard,3,MIP urogram,Split bolus critical for opacification. Lasix may help. Prone imaging optional for ureters,abdomen,100-120,Auto (reference 200),0.5,1.0-1.375,MIP urogram coronal and sagittal. Curved MPR of ureters. 3D urogram,
CT Adrenal Mass Protocol,2024-01-15,Dr. Thompson,Adrenal mass characterization | Adenoma vs metastasis | Incidentaloma workup,Supine with arms raised,NPO 4 hours,None,Omnipaque 350,1.5 mL/kg,3-4 mL/s,Triple phase: NC + Portal venous + 15 min delay,N/A,N/A,Full dose if eGFR > 30,THREE phases: 1) Non-contrast for absolute HU 2) Portal venous 70s 3) 15 MINUTE delayed for washout. All phases cover adrenals,18-20G IV. Patient must wait 15 min for delayed phase,NC: lipid-rich adenoma < 10 HU. Portal venous: enhancement. 15 min delay: calculate washout (adenoma shows washout),150mL (70kg),40s,50mL,13s,Adrenals,Triple phase,done,Variable,Multiple,Verify eGFR > 30,Check allergy history. Explain 15 min delay,Scout,Diaphragm,Kidneys,N/A,N/A,AP,Non-Contrast,Diaphragm,Kidneys,N/A,2.5 mm,Measure absolute HU in mass,Portal Venous,Diaphragm,Kidneys,70 sec,2.5 mm,Enhanced HU measurement,15 Minute Delay,Diaphragm,Kidneys,15 min (900 sec),2.5 mm,Delayed HU for washout calculation,,,,,,,Axial,All phases,Adrenals,2.5 mm/2.5 mm,Standard,3,ROI measurements in mass,Axial,All phases,Adrenals,2.5 mm/2.5 mm,Standard,3,Compare enhancement,Coronal,Portal venous,Adrenals,3 mm/3 mm,Standard,3,Anatomic overview,,,,,,,,Patient wait time 15 min. Measure HU carefully with ROI in same location,abdomen,120,Auto (reference 200),0.5,1,Calculate absolute washout: (Enhanced HU - Delayed HU)/(Enhanced HU - NC HU) x 100. >60% suggests adenoma. Measure HU in all phases,
CT Cystogram,2024-01-15,Dr. Kim,Bladder rupture | Bladder injury | Post-operative bladder assessment | Hematuria with bladder concern,Supine,NPO 2-4 hours,None,Omnipaque 350 diluted,IV: 100 mL. Bladder: 350-400 mL dilute contrast (30 mL contrast in 350 mL saline),3-4 mL/s IV,Portal venous + Cystogram,N/A,N/A,eGFR > 30 for IV. Bladder instillation via Foley,TWO components: 1) CT with IV contrast portal venous 2) Bladder filling via Foley with dilute contrast 3) Scan distended bladder 4) Post-void scan. Coordinate with nursing,Foley catheter required. Dilute contrast preparation (30mL in 350mL saline). Gravity fill bladder. Patient signals fullness,Portal venous: solid organs. Cystogram: bladder integrity extravasation. Post-void: small leaks,100mL,27s,50mL,13s,Pelvis,Portal venous + Cystogram,done,1:10,Multiple,Verify eGFR > 30,Foley placement. Prepare dilute contrast,Scout,Diaphragm,Pubic symphysis,N/A,N/A,AP,Portal Venous,Diaphragm,Pubic symphysis,70 sec,2.5 mm,Standard IV contrast,Bladder Filling,N/A,N/A,During filling,N/A,Fill via Foley - not scanned,Cystogram,Iliac crests,Below bladder,After filling,2 mm,Scan distended bladder,Post-Void,Iliac crests,Below bladder,After voiding,2 mm,Scan after drainage,Axial,Cystogram,Pelvis,2 mm/2 mm,Standard,3,Distended bladder assessment,Axial,Post-void,Pelvis,2 mm/2 mm,Standard,3,Look for extravasation,Coronal,Cystogram,Pelvis,2.5 mm/2.5 mm,Standard,3,Bladder overview,Sagittal,Cystogram,Pelvis,2.5 mm/2.5 mm,Standard,3,Bladder dome and base,Adequate bladder distension critical. Gravity fill slowly. Clamp Foley during scan,abdomen,120,Auto (reference 200),0.5,1,Compare distended vs post-void. Document extravasation location. 3D reformation if complex injury,
Trauma Head and C-Spine,2024-01-15,Dr. Smith,Trauma head injury | C-spine clearance | Multi-trauma assessment,Supine head-first. Cervical collar in place,None - trauma,None,None,None,None,Non-contrast,N/A,N/A,No contrast. Trauma indication,TWO acquisitions: 1) Head vertex to C1 2) C-spine skull base to T1. Head: 5mm axial. C-spine: 0.625mm with reformats. Minimize movement,Maintain cervical precautions. C-collar remains on. Document GCS,Head: acute hemorrhage skull fractures. C-spine: fractures alignment ligamentous injury,N/A,N/A,N/A,N/A,Head/C-spine,Non-contrast scans,done,0:00,20s,N/A,N/A,Scout Head,Vertex,C1,N/A,N/A,Lateral,NC Head,Vertex,Foramen magnum,N/A,5 mm,Parallel to hard palate,Scout C-spine,Skull base,T1,N/A,N/A,AP and lateral,NC C-spine,Skull base,T1,N/A,0.625 mm,Helical submillimeter,,,,,,,Axial,Head,Brain,5 mm/5 mm,Brain,3,Brain and bone windows,Sagittal,C-spine,C-spine,2 mm/2 mm,Bone,3,Midline and parasagittal,Coronal,C-spine,C-spine,2 mm/2 mm,Bone,3,Coronal alignment,Axial,C-spine,C-spine,2 mm/2 mm,Bone,3,Axial bone windows,Keep C-collar on. Minimize patient movement,trauma,120,Auto (300 head / 250 spine),1.0 head / 0.5 spine,0.5,C-spine: Sagittal and coronal bone reformats. 3D if complex fracture,
Trauma Head C-Spine and Facial Bones,2024-01-15,Dr. Johnson,Facial trauma | Maxillofacial fractures | Orbital fractures with head/spine injury,Supine head-first. C-collar on,None - trauma,None,None,None,None,Non-contrast,N/A,N/A,No contrast,THREE acquisitions: 1) Head 2) C-spine 3) Facial bones. Face: submillimeter helical for 3D. C-collar remains,C-collar precautions. Document mechanism of injury,Head: intracranial injury. C-spine: fractures. Face: Le Fort midface orbital mandible fractures,N/A,N/A,N/A,N/A,Head/C-spine/Face,Non-contrast scans,done,0:00,30s,N/A,N/A,Scout,Vertex,T1,N/A,N/A,Lateral,NC Head,Vertex,Foramen magnum,N/A,5 mm,Standard head,NC C-spine,Skull base,T1,N/A,0.625 mm,Submillimeter,NC Facial Bones,Frontal sinus,Mandible,N/A,0.625 mm,Submillimeter for 3D,,,,,,,Axial,Head,Brain,5 mm/5 mm,Brain/Bone,3,Brain and skull,Sagittal,C-spine,C-spine,2 mm/2 mm,Bone,3,C-spine alignment,Axial,Face,Face,1.25 mm/1 mm,Bone,N/A,Facial bones,Coronal,Face,Face,1.25 mm/1 mm,Bone,N/A,Facial coronal,C-collar on. Remove dentures if safe,trauma,120,Auto (300 head / 250 other),1.0 / 0.5,0.5,3D face reconstruction. Le Fort classification. Orbital floor assessment,
Trauma Chest CT,2024-01-15,Dr. Martinez,Blunt chest trauma | Rib fractures | Pneumothorax | Hemothorax,Supine with arms raised if possible,None - trauma,None,None,None,None,Non-contrast,N/A,N/A,No contrast for initial chest trauma,Single acquisition lung apices to costophrenic angles. RIB REFORMATS required. Submillimeter acquisition,Trauma precautions. Arms up if able,Pneumothorax hemothorax. Rib fractures (count and location). Pulmonary contusion. Aortic injury. Sternal/scapular fractures,N/A,N/A,N/A,N/A,Chest,Non-contrast scan,done,0:00,10s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,AP and lateral,NC Chest,Lung apices,Costophrenic angles,N/A,0.625-1 mm,Submillimeter for ribs,,,,,,,,,,,,,,,,,,,Axial,Chest,Chest,2.5 mm/2.5 mm,Standard,3,Mediastinal window,Axial,Chest,Chest,2.5 mm/2.5 mm,Lung,3,Lung window,Coronal,Chest,Chest,2.5 mm/2.5 mm,Bone,N/A,Rib overview,Oblique sagittal,Chest,Ribs,2 mm/2 mm,Bone,N/A,Rib reformats all ribs,Submillimeter acquisition critical for rib detail,trauma,120,Auto (reference 200),0.5,1.0-1.2,Dedicated rib reformats (oblique sagittal each rib). Count fractures. 3D chest wall,
Trauma CTA Chest with PV CT AP,2024-01-15,Dr. Lee,Blunt thoracic trauma | Aortic injury | Great vessel injury | Multi-trauma,Supine with arms raised,None - trauma,None,Omnipaque 350,125 mL,4 mL/s,Dual phase: CTA Chest arterial + Portal venous AP,Descending aorta,150 HU,Proceed if possible. Document medical necessity,TWO acquisitions: 1) CTA CHEST arterial (bolus track) 2) Portal venous ABDOMEN/PELVIS 70s. Chest arterial for aorta/vessels,Large bore IV 18-20G. Verify flow,Chest arterial: aortic injury (intimal flap pseudoaneurysm). AP portal venous: solid organ injury,125mL,31s,50mL,13s,Chest + AP,Arterial chest + PV AP,crit,Variable,40s,eGFR > 30 if known,Trauma indication,Scout,Lung apices,Pubic symphysis,N/A,N/A,AP full,CTA Chest,Lung apices,Diaphragm,Bolus tracked,0.625 mm,Arterial phase,Portal Venous AP,Diaphragm,Pubic symphysis,70 sec from start,0.625 mm,Portal venous phase,,,,,,,,,,,,,Axial,CTA chest,Chest,1.25 mm/1.25 mm,Vascular,3,Aorta and great vessels,Axial,PV AP,Abdomen/Pelvis,2.5 mm/2.5 mm,Standard,3,Solid organs,Coronal,CTA chest,Chest,2 mm/2 mm,Vascular,3,Aorta overview,Sagittal,CTA chest,Aorta,2 mm/2 mm,Vascular,3,Sagittal aorta,Trauma indication. Fast scan. Good IV essential,trauma,100-120,Auto (reference 250),0.5,1.0-1.2,3D aorta and great vessels. Curved MPR aorta. Grade aortic injury,
Trauma Lower Extremity Runoff CTA,2024-01-15,Dr. Williams,Extremity vascular injury | Penetrating trauma | Fracture with vascular concern | Pulseless extremity,Supine legs extended,None - trauma,None,Omnipaque 350,125 mL,4-5 mL/s,Bolus Tracking,Abdominal aorta or proximal to injury,150 HU,Proceed with trauma indication,Extend coverage based on injury. Aorta to ankles if bilateral. May do unilateral focused study. Arterial phase,18-20G IV. May need proximal IV if arm injury,Assess arterial injury: transection pseudoaneurysm occlusion extravasation. Evaluate fracture relationship to vessels,125mL,28s,50mL,11s,Lower extremity,Arterial phase,crit,0:28,30s,Check if available,Trauma indication,Scout,Aorta or pelvis,Ankles,N/A,N/A,AP legs,CTA Arterial,Coverage as needed,Distal to injury,Bolus tracked,0.625 mm,Arterial phase runoff,,,,,,,,,,,,,,,,,,,Axial,Arterial,Legs,1.5 mm/1.5 mm,Vascular,3,Assess vessels,Coronal,Arterial,Legs,2 mm/2 mm,Vascular,3,MIP overview,Sagittal,Arterial,Injured area,2 mm/2 mm,Vascular,3,Vessel-bone relationship,3D VR,Arterial,Vessels,1 mm source,Vascular,3,3D vascular anatomy,Tailor coverage to injury. Fast acquisition,trauma,100-120,Auto (reference 250),0.5,1.2-1.5,MIP and 3D VR. Document vascular injury. Measure vessel caliber,
Trauma Code AAA,2024-01-15,Dr. Davis,Ruptured AAA | Aortic emergency | Hemodynamic instability with abdominal pain,Supine with arms raised,None - emergency,None,Omnipaque 350,125 mL,4-5 mL/s,Triple phase: NC + Arterial + Portal venous,Abdominal aorta,150 HU,Proceed emergently. Life-saving indication,RAPID triple phase: 1) NC CAP (hematoma) 2) Arterial CAP (active bleed bolus track 25-30s) 3) Portal venous CAP (70s). STAT protocol,Large bore IV 18G minimum. Blood products ready,NC: retroperitoneal hematoma. Arterial: active extravasation aneurysm morphology. Portal: solid organs,125mL,31s,50mL,13s,CAP,Triple phase emergency,crit,Variable,60s total,Emergent - proceed,Document emergency,Scout,Diaphragm,Pubic symphysis,N/A,N/A,STAT,Non-Contrast CAP,Diaphragm,Pubic symphysis,N/A,2.5 mm,RAPID - hematoma,Arterial CAP,Diaphragm,Pubic symphysis,25-30 sec,0.625 mm,Active bleeding + aneurysm,Portal Venous CAP,Diaphragm,Pubic symphysis,70 sec,2.5 mm,Organs and venous,,,,,,,Axial,All phases,CAP,2.5 mm/2.5 mm,Vascular/Standard,3,Compare phases,Coronal,Arterial,CAP,2.5 mm/2.5 mm,Vascular,3,Aorta and bleeding,Sagittal,Arterial,Aorta,2 mm/2 mm,Vascular,3,Aorta extent,3D VR,Arterial,Aorta,1.5 mm,Vascular,3,STAT 3D for EVAR planning,STAT protocol. Minimize delays. Notify vascular surgery,trauma,100-120,High mAs (300 reference),0.5,1.0-1.375,Measure aneurysm. Identify bleeding site. EVAR measurements if stable,
Pregnant Trauma CT AP,2024-01-15,Dr. Anderson,Pregnant trauma patient | Multi-trauma pregnancy | Maternal injury assessment,Supine with left lateral tilt if possible,None - trauma,None,Omnipaque 350,125 mL,3 mL/s,Portal venous,N/A,N/A,Proceed with trauma indication. Document medical necessity and gestational age,Portal venous phase 70s. SINGLE PHASE to minimize fetal radiation. Shield uterus if injury distant. Document weeks gestation,Pregnancy documented. Fetal heart tones if equipment available. Shield if possible,Assess maternal injuries. Minimize fetal radiation exposure. Document placental injury if visible,125mL,42s,50mL,17s,Abdomen/Pelvis,Portal venous phase,done,1:10,25s,Check if known,Trauma indication documented,Scout,Diaphragm,Pubic symphysis,N/A,N/A,Low dose scout,Portal Venous AP,Diaphragm,Pubic symphysis,70 sec,2.5 mm,Single phase minimize radiation,,,,,,,,,,,,,,,,,,,Axial,Portal venous,AP,2.5 mm/2.5 mm,Standard,3,Maternal organs,Coronal,Portal venous,AP,3 mm/3 mm,Standard,3,Overview,Sagittal,Portal venous,Pelvis,3 mm/3 mm,Standard,3,Uterus and placenta,,,,,,,,Document gestational age. Shield fetus if possible. Minimize radiation,trauma,100,Reduced mAs if possible,0.5,1.375,,
Non-Contrast CT Chest Routine,2024-01-15,Dr. Thompson,Pulmonary nodule | Interstitial lung disease screening | Chest pain low risk | Follow-up,Supine with arms raised,None,None,None,None,None,Non-contrast,N/A,N/A,No contrast required,Standard dose helical chest. Lung apices to costophrenic angles. Routine lung and mediastinal windows,No IV needed. Breath hold coaching,Assess lung parenchyma nodules masses. Mediastinal lymph nodes. Pleura. Incidental findings,N/A,N/A,N/A,N/A,Chest,Non-contrast scan,done,0:00,8s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,AP and lateral,NC Chest,Lung apices,Costophrenic angles,N/A,1-1.25 mm,Standard dose helical,,,,,,,,,,,,,,,,,,,Axial,Chest,Chest,2.5 mm/2.5 mm,Standard,3,Mediastinal window,Axial,Chest,Chest,2.5 mm/2.5 mm,Lung,3,Lung window,Coronal,Chest,Chest,3 mm/3 mm,Lung,3,Coronal lung,Sagittal,Chest,Chest,3 mm/3 mm,Standard,3,Optional mediastinum,Full inspiration breath hold,chest,120,Auto (reference 200),0.5,1.0-1.2,Thin slice 1mm for nodule detection and measurement,
Non-Contrast CT Chest Low Dose,2024-01-15,Dr. Kim,Lung cancer screening | Low risk pulmonary nodule follow-up | Smoking history screening,Supine with arms raised,None,None,None,None,None,Non-contrast low dose,N/A,N/A,No contrast. Lung cancer screening protocol,LOW DOSE technique. Reduced mAs 30-50% of standard. Helical acquisition. High IR strength,No IV. Explain screening purpose and low radiation,Lung nodule detection. Measure nodules. Lung-RADS classification. Emphysema assessment,N/A,N/A,N/A,N/A,Chest,Low dose scan,done,0:00,8s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,Low dose AP,Low Dose Chest,Lung apices,Costophrenic angles,N/A,1-1.25 mm,Low dose helical,,,,,,,,,,,,,,,,,,,Axial,Chest,Chest,1.25 mm/1.25 mm,Lung,High IR 4-5,Thin slice nodule detection,Axial,Chest,Chest,2.5 mm/2.5 mm,Standard,3,Mediastinal window,Coronal,Chest,Chest,2 mm/2 mm,Lung,High IR,Coronal overview,MIP,Chest,Lungs,5 mm slab,Lung,N/A,Nodule detection,Low dose protocol. High iterative reconstruction. Nodule measurement software,chest,100-120,Low dose (40-60 reference),0.5,1.0-1.2,CAD nodule detection. Measure all nodules 3mm. Lung-RADS reporting,
Non-Contrast Chest Lung Nodule Ultra Low Dose,2024-01-15,Dr. Rodriguez,Pulmonary nodule follow-up | Known nodule surveillance | Post-treatment monitoring,Supine with arms raised,None,None,None,None,None,Non-contrast ultra low dose,N/A,N/A,No contrast. Ultra low dose for follow-up only,ULTRA LOW DOSE 10-20% standard dose. For follow-up of KNOWN nodules only. Not for initial detection. Maximum IR,No IV. Known nodule follow-up only,Follow known nodules. Compare to prior. Measure size. Not for initial detection,N/A,N/A,N/A,N/A,Chest,Ultra low dose,done,0:00,8s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,Ultra low dose,Ultra Low Dose Chest,Lung apices,Costophrenic angles,N/A,1-1.25 mm,Ultra low dose helical,,,,,,,,,,,,,,,,,,,Axial,Chest,Chest,1.25 mm/1.25 mm,Lung,Maximum IR 5,Nodule follow-up,Axial,Chest,Chest,2.5 mm/2.5 mm,Standard,High IR,Mediastinal,Coronal,Chest,Chest,2 mm/2 mm,Lung,Maximum IR,Coronal,,,,,,,,Ultra low dose. Maximum IR. Prior comparison essential,chest,100,Ultra low (20-30 reference),0.5,1.0-1.2,,
Volumetric HRCT 2 Respiratory Phases,2024-01-15,Dr. White,Interstitial lung disease initial evaluation | ILD diagnosis | Diffuse lung disease,Supine with arms raised,None,None,None,None,None,Non-contrast volumetric,N/A,N/A,No contrast. ILD protocol,TWO acquisitions: 1) Full INSPIRATION 2) Limited EXPIRATION (carina to bases). Volumetric (contiguous thin slice). Coach breathing,No IV. Careful breath hold coaching. Inspiration and expiration,ILD pattern recognition. Honeycombing. Ground glass. Reticular. Mosaic attenuation on expiration,N/A,N/A,N/A,N/A,Chest,Dual phase HRCT,done,0:00,15s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,AP lateral,Volumetric Inspiration,Lung apices,Costophrenic angles,Full inspiration,1 mm,Contiguous 1mm slices,Limited Expiration,Carina,Costophrenic angles,Full expiration,1 mm,Limited coverage expiration,,,,,,,,,,,,,Axial,Inspiration,Chest,1 mm/1 mm,Lung,3,Thin slice ILD assessment,Axial,Expiration,Lower lungs,1 mm/1 mm,Lung,3,Air trapping assessment,Coronal,Inspiration,Chest,1.5 mm,Lung,3,ILD distribution,Sagittal,Inspiration,Chest,2 mm,Lung,3,Craniocaudal distribution,Volumetric contiguous slices. Coach breathing carefully,chest,120,Auto (reference 150-200),0.5,1,Thin slice for ILD detail. Compare inspiration vs expiration. Quantitative analysis if available,
Non-Volumetric HRCT 3 Respiratory Phases,2024-01-15,Dr. Hayes,Air trapping assessment | Small airways disease | Constrictive bronchiolitis | Hypersensitivity pneumonitis,Supine with arms raised,None,None,None,None,None,Non-contrast sequential,N/A,N/A,No contrast. Air trapping protocol,THREE acquisitions: 1) INSPIRATION 2) MID-EXPIRATION 3) FULL EXPIRATION. Non-volumetric (1-2cm intervals). Lower dose than volumetric,No IV. Coach three breathing phases carefully,Mosaic attenuation. Air trapping. Small airways disease. Compare three phases,N/A,N/A,N/A,N/A,Chest,Triple phase HRCT,done,0:00,12s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,AP,Inspiration,Lung apices,Costophrenic angles,Full inspiration,1 mm axial at 1-2cm intervals,Sequential non-volumetric,Mid-Expiration,Lung apices,Costophrenic angles,Mid-expiration,1 mm at intervals,Sequential,Full Expiration,Lung apices,Costophrenic angles,Full expiration,1 mm at intervals,Sequential,,,,,,,Axial,All phases,Chest,1 mm display,Lung,3,Compare three phases,Coronal reformat,Inspiration,Chest,2 mm,Lung,3,Inspiration overview,Mosaic MIP,All phases,Lungs,5 mm,Lung,N/A,Air trapping visualization,,,,,,,,Coach three distinct breath holds. Non-volumetric lower dose,chest,120,Reduced (100-150 reference),Sequential,N/A,Side-by-side comparison of three phases. Quantify air trapping,
Non-Volumetric HRCT 1 Respiratory Phase,2024-01-15,Dr. Chen,HRCT follow-up | Known ILD monitoring | Bronchiectasis assessment,Supine with arms raised,None,None,None,None,None,Non-contrast sequential,N/A,N/A,No contrast,Single INSPIRATION phase. Non-volumetric (1-2cm intervals). Lower dose for follow-up,No IV. Single inspiration breath hold,Follow ILD changes. Bronchiectasis. Lower radiation than volumetric,N/A,N/A,N/A,N/A,Chest,Single phase HRCT,done,0:00,5s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,AP,HRCT Inspiration,Lung apices,Costophrenic angles,Full inspiration,1 mm at 1-2cm intervals,Sequential slices,,,,,,,,,,,,,,,,,,,Axial,HRCT,Chest,1 mm display,Lung,3,HRCT images,Coronal,HRCT,Chest,2 mm,Lung,3,Coronal overview,Targeted,HRCT,Area of interest,1 mm,Lung,3,Focus on abnormality,,,,,,,,Non-volumetric reduces dose. Good for follow-up,chest,120,Reduced (100-150 reference),Sequential,N/A,Target slices through abnormality. Compare to prior,
Non-Volumetric HRCT 1 Phase Prone,2024-01-15,Dr. Martinez,Dependent atelectasis vs fibrosis | Posterior lung assessment | ILD with gravity-dependent changes,Prone with arms extended forward,None,None,None,None,None,Non-contrast sequential,N/A,N/A,No contrast. Prone positioning,Single INSPIRATION. PRONE position. Non-volumetric (1-2cm intervals). Distinguish atelectasis from fibrosis,Position patient prone safely. Cushion support. Breath hold coaching,Differentiate dependent atelectasis from true fibrosis. Posterior lung better aerated prone,N/A,N/A,N/A,N/A,Chest,Prone HRCT,done,0:00,5s,N/A,N/A,Scout Prone,Lung apices,Costophrenic angles,N/A,N/A,Lateral,HRCT Prone,Lung apices,Costophrenic angles,Full inspiration,1 mm at 1-2cm intervals,Sequential prone,,,,,,,,,,,,,,,,,,,Axial,HRCT prone,Chest,1 mm display,Lung,3,Prone images,Coronal,HRCT prone,Chest,2 mm,Lung,3,Coronal prone,Compare,Supine vs prone,Posterior lungs,1 mm,Lung,3,Dependent changes,,,,,,,,Safe prone positioning. Compare to supine if available,chest,120,Reduced (100-150 reference),Sequential,N/A,Compare prone to supine to differentiate atelectasis from fibrosis,
Dynamic Airway CT,2024-01-15,Dr. Lee,Tracheomalacia | Bronchomalacia | Expiratory central airway collapse | EDAC,Supine with arms raised,None,None,None,None,None,Non-contrast dynamic,N/A,N/A,No contrast. Airway dynamics,TWO acquisitions: 1) INSPIRATION carina to carina+10cm 2) MID-EXPIRATION same level. Cine if available. Airway reconstructions required,No IV. Coach dynamic breathing. May need forced expiration,Measure tracheal collapse percentage. >50% collapse suggests tracheomalacia. Assess bronchi,N/A,N/A,N/A,N/A,Airway,Dynamic phases,done,0:00,10s,N/A,N/A,Scout,Thoracic inlet,Carina+10cm,N/A,N/A,Lateral,Inspiration,Thoracic inlet,Carina+10cm,Full inspiration,0.625-1 mm,Thin for 3D,Mid-Expiration,Thoracic inlet,Carina+10cm,Forced mid-expiration,0.625-1 mm,Same level as inspiration,Cine (optional),Carina level,Single slice,Continuous breathing,Cine mode,Dynamic collapse,,,,,,,Axial,Both phases,Airway,1-2 mm/1 mm,Lung,3,Axial airway,Coronal,Both phases,Airway,1.5 mm,Lung,3,Coronal airway,Sagittal,Both phases,Airway,1.5 mm,Lung,3,Sagittal airway,3D VR,Both phases,Airway,0.625-1 mm source,Lung,N/A,3D airway reconstruction,Coach forced expiration. Exact same level both phases,chest,120,Auto (reference 200),0.5,Helical,Measure tracheal AP diameter inspiration vs expiration. Calculate collapse percentage. 3D airway,
Quantitative Lung Density CT,2024-01-15,Dr. Patel,Emphysema quantification | COPD assessment | Alpha-1 antitrypsin deficiency | Pre-LVRS,Supine with arms raised,None,None,None,None,None,Non-contrast volumetric,N/A,N/A,No contrast. Quantitative protocol,TWO VOLUMETRIC acquisitions: 1) Full INSPIRATION 2) FULL EXPIRATION (complete exhalation). Contiguous thin slices. Quantitative software,No IV. Coach complete inspiration and complete expiration,Quantify emphysema (% lung <-950 HU inspiration). Air trapping (% lung <-856 HU expiration). Emphysema distribution,N/A,N/A,N/A,N/A,Chest,Inspiration + Expiration,done,0:00,15s,N/A,N/A,Scout,Lung apices,Costophrenic angles,N/A,N/A,AP lateral,Volumetric Inspiration,Lung apices,Costophrenic angles,Full inspiration (TLC),0.625-1 mm,Contiguous for quantification,Volumetric Expiration,Lung apices,Costophrenic angles,Full expiration (RV),0.625-1 mm,Contiguous complete exhalation,,,,,,,,,,,,,Axial,Inspiration,Chest,1 mm/1 mm,Lung,3,Quantitative inspiration,Axial,Expiration,Chest,1 mm/1 mm,Lung,3,Quantitative expiration,Density map,Inspiration,Lungs,Color coded,Lung,N/A,Emphysema distribution map,Density map,Expiration,Lungs,Color coded,Lung,N/A,Air trapping map,Complete exhalation critical for RV. Volumetric contiguous,chest,120,Auto (reference 150-200),0.5,1,Quantitative emphysema analysis. Report % lung <-950 HU. Air trapping metrics. Upper/lower lobe distribution,
Brain Stroke Protocol,2024-01-15,Dr. Williams,Acute stroke | CVA | Neurological deficit < 24 hours | Stroke code,Supine head-first,None - emergency,None,Omnipaque 350 for CTA/CTP,100 mL,4-5 mL/s,Multi-phase stroke protocol,Multiple ROIs,Varies,Proceed emergently. Time is brain,STAT protocol: 1) NC Head 2) CTA Head/Neck (aortic arch to vertex) 3) CTP (optional). Minimize door-to-scan time,No IV for NC. Large bore for CTA/CTP. STAT coordination,NC: hemorrhage early ischemia hyperdense vessel. CTA: LVO large vessel occlusion. CTP: penumbra core mismatch,100mL,23s,40mL,10s,Head/Neck,Multi-phase stroke,crit,Variable,45s total,Emergency proceed,STAT protocol,Scout,Vertex,Aortic arch,N/A,N/A,STAT lateral,NC Head,Vertex,Foramen magnum,N/A,5 mm,STAT no contrast,CTA Head,Skull base,Vertex,Bolus tracked aorta,0.625 mm,Intracranial vessels,CTA Neck,Aortic arch,Skull base,Continues from head,0.625 mm,Extracranial vessels,CTP (optional),Basal ganglia level,8cm slab,Auto-triggered,5 mm dynamic,Perfusion if candidate,Axial,NC head,Brain,5 mm/5 mm,Brain,3,STAT hemorrhage detection,Axial,CTA head,Brain,1 mm/1 mm,Brain,3,LVO detection,MIP,CTA,Circle of Willis,Thick slab,Brain,N/A,Vessel overview,CTP maps,CTP,Perfusion,Color maps,N/A,N/A,CBF CBV MTT Tmax maps,STAT protocol. Minimize delays. LVO detection critical,neuro,120,Auto (300 head),1.0 / 0.5,0.5,CTA MIP and 3D. CTP perfusion maps if done. ASPECTS score. LVO documentation,
CTA Head,2024-01-15,Dr. Thompson,Aneurysm screening | Subarachnoid hemorrhage | Vascular malformation | Intracranial stenosis,Supine head-first,NPO 2 hours,None,Omnipaque 350,75-100 mL,4-5 mL/s,Bolus Tracking,Aortic arch or carotid,150 HU,Full dose if eGFR > 30,NC Head optional then CTA skull base to vertex. Bolus tracking. Submillimeter for 3D reconstruction,20G IV minimum. Good bolus essential,Assess circle of Willis. Aneurysms. Stenosis. Vascular malformations. Anatomic variants,90mL,20s,40mL,10s,Head,Intracranial arterial,crit,0:22,8s,Verify eGFR > 30,Check allergy history,Scout,Vertex,C1,N/A,N/A,Lateral,NC Head (optional),Vertex,Foramen magnum,N/A,5 mm,Baseline if SAH,CTA Head,Skull base,Vertex,Bolus tracked,0.5-0.625 mm,Submillimeter for 3D,,,,,,,,,,,,,Axial,CTA,Head,0.75 mm/0.75 mm,Brain,3,Source images,MIP,CTA,Circle of Willis,Thick slab,Brain,N/A,Vessel overview,3D VR,CTA,Intracranial vessels,0.5 mm source,Brain,N/A,3D angiogram,Curved MPR,CTA,Individual vessels,0.75 mm,Brain,3,Vessel-specific views,Minimize motion. Thin slices for small aneurysms,neuro,100-120,Auto (reference 250),0.5-0.6,Helical,3D VR and MIP. Measure aneurysm if present. Assess A1 A2 dominance,
CTA Neck,2024-01-15,Dr. Kim,Carotid stenosis | Vertebral artery dissection | Neck vessel assessment | Pre-CEA planning,Supine head-first,NPO 2 hours,None,Omnipaque 350,90-100 mL,4-5 mL/s,Bolus Tracking,Aortic arch,150 HU,Full dose if eGFR > 30,Aortic arch to skull base. Bolus tracking in arch. Submillimeter. Minimize swallowing during scan,20G IV antecubital preferred,Assess carotid bifurcations. Stenosis grading. Vertebral arteries. Dissection. Plaque morphology,100mL,23s,40mL,10s,Neck,Arterial phase,crit,0:25,12s,Verify eGFR > 30,Check allergy history,Scout,Aortic arch,Skull base,N/A,N/A,AP lateral,CTA Neck,Aortic arch,Skull base,Bolus tracked,0.625 mm,Caudocranial,,,,,,,,,,,,,,,,,,,Axial,CTA,Neck,1 mm/1 mm,Vascular,3,Source images,Coronal,CTA,Neck,1.5 mm,Vascular,3,Vessel overview,Sagittal,CTA,Carotids,1.5 mm,Vascular,3,Vertebral arteries,Curved MPR,CTA,Carotid bifurcations,1 mm,Vascular,3,Stenosis measurement,Minimize swallowing. Submillimeter acquisition,neuro,100-120,Auto (reference 200),0.5,0.9,Curved MPR both carotid bifurcations. Measure stenosis (NASCET). 3D VR. MIP,
CTV Head,2024-01-15,Dr. Rodriguez,Venous sinus thrombosis | Dural sinus thrombosis | Intracranial hypertension | Venous malformation,Supine head-first,NPO 2 hours,None,Omnipaque 350,75-100 mL,3-4 mL/s,Fixed delay venous,N/A,N/A,Full dose if eGFR > 30,NC Head then delayed venous CTV (60-90 sec). Skull base to vertex. Assess venous sinuses,18-20G IV,NC: hemorrhage. CTV: filling defects in sinuses. Venous thrombosis. Cortical vein thrombosis,90mL,25s,40mL,11s,Head,Venous phase,done,1:30,8s,Verify eGFR > 30,Check allergy history,Scout,Vertex,C1,N/A,N/A,Lateral,NC Head,Vertex,Foramen magnum,N/A,5 mm,Baseline,CTV Head,Skull base,Vertex,60-90 sec delay,0.625-1 mm,Venous phase,,,,,,,,,,,,,Axial,CTV,Head,1 mm/1 mm,Brain,3,Venous sinuses,MIP,CTV,Sinuses,Thick slab,Brain,N/A,Venogram overview,3D VR,CTV,Venous system,1 mm source,Brain,N/A,3D venogram,Sagittal,CTV,Midline,1.5 mm,Brain,3,Sagittal sinus,Delayed timing 60-90 sec. Look for filling defects,neuro,120,Auto (reference 250),0.5-0.6,Helical,3D VR venogram. MIP maximum intensity projection. Document filling defects,
CT Sinus,2024-01-15,Dr. Hayes,Sinusitis | Sinus disease | Pre-operative sinus surgery | Nasal obstruction,Supine head-first,None,None,None,None,None,Non-contrast,N/A,N/A,No contrast,Coronal acquisition skull base through maxillary sinuses. Submillimeter for anatomy. Bone and soft tissue windows,No IV. Remove dentures and metal,Assess all sinuses. Ostiomeatal complex. Anatomic variants. Mucosal thickening. Polyps. Bony anatomy,N/A,N/A,N/A,N/A,Sinuses,Non-contrast scan,done,0:00,5s,N/A,N/A,Scout,Frontal sinus,Maxillary sinus,N/A,N/A,Lateral,Coronal Sinus,Frontal sinus,Maxillary sinus,N/A,0.625 mm,Direct coronal if possible,Axial reformat,Frontal,Maxillary,From coronal,0.625 mm,Reformatted from coronal,,,,,,,,,,,,,Coronal,Sinus,Sinuses,1.25 mm/0.75 mm,Bone,N/A,Bone window,Coronal,Sinus,Sinuses,3 mm/2 mm,Standard,3,Soft tissue,Axial,Sinus,Sinuses,2 mm/2 mm,Bone,N/A,Axial bone,Sagittal,Sinus,Sinuses,2 mm/2 mm,Bone,N/A,Midline and lateral,Direct coronal preferred. Submillimeter for anatomy,neuro,120,Auto (reference 200),Axial or coronal,N/A,Document anatomic variants (Haller cells concha bullosa). OMC assessment,
CT Sinus Stereotactic,2024-01-15,Dr. Chen,Pre-operative sinus surgery planning | Image-guided surgery | ENT surgical navigation,Supine head-first. Surgical planning position,None,None,None,None,None,Non-contrast stereotactic,N/A,N/A,No contrast. Surgical navigation,Submillimeter isotropic acquisition. DICOM for surgical navigation system. May need fiducial markers. Entire sinus anatomy,Position as for surgery. Fiducials if required,Complete sinus anatomy for surgical navigation. Ostiomeatal complex. Skull base. Lamina papyracea,N/A,N/A,N/A,N/A,Sinuses,Stereotactic scan,done,0:00,8s,N/A,N/A,Scout,Frontal sinus,Hard palate,N/A,N/A,Lateral,Stereotactic Sinus,Frontal sinus,Hard palate,N/A,0.625 mm,Isotropic submillimeter,,,,,,,,,,,,,,,,,,,Axial,Stereo,Sinuses,0.625 mm/0.625 mm,Bone,N/A,Isotropic bone,Coronal,Stereo,Sinuses,0.625 mm/0.625 mm,Bone,N/A,Isotropic coronal,Sagittal,Stereo,Sinuses,0.625 mm/0.625 mm,Bone,N/A,Isotropic sagittal,3D surface,Stereo,Sinuses,0.625 mm source,Bone,N/A,Surface rendering for navigation,Isotropic voxels essential. DICOM for navigation,neuro,120,Auto (reference 200),Helical,Pitch for isotropic,Export DICOM to surgical navigation system. Isotropic 0.625mm,
CT Facial Bones,2024-01-15,Dr. Martinez,Facial trauma | Orbital fractures | Zygoma fractures | Nasal fractures | Mandible fractures,Supine head-first,None,None,None,None,None,Non-contrast,N/A,N/A,No contrast. Trauma or facial injury,Frontal sinus to mandible. Submillimeter for 3D. Axial acquisition with multiplanar reformats. Remove dentures,Remove all facial metal. Dentures out,Le Fort classification. Orbital floor. Zygoma. Nasal bones. Mandible. NOE complex. 3D for surgical planning,N/A,N/A,N/A,N/A,Face,Non-contrast scan,done,0:00,8s,N/A,N/A,Scout,Frontal sinus,Mandible,N/A,N/A,Lateral,Facial Bones,Frontal sinus,Mandible,N/A,0.625 mm,Submillimeter for 3D,,,,,,,,,,,,,,,,,,,Axial,Face,Face,1.25 mm/1 mm,Bone,N/A,Axial bone windows,Coronal,Face,Face,1.25 mm/1 mm,Bone,N/A,Coronal face,Sagittal,Face,Midface,2 mm/1.5 mm,Bone,N/A,Sagittal midline,3D,Face,Facial bones,0.625 mm source,Bone,N/A,3D surface rendering,Remove dentures and facial metal,neuro,120,Auto (reference 250),0.5,Helical,3D surface rendering. Document Le Fort if present. Orbital floor assessment,
CT Head 3D Stereotactic,2024-01-15,Dr. Lee,Stereotactic surgery planning | DBS planning | Biopsy planning | Surgical navigation | Gamma knife,Supine in surgical position. Head in frame if required,None,None,None typically. Contrast optional,If contrast: 100 mL,3 mL/s,Non-contrast or contrast,N/A,N/A,No contrast unless tumor. Stereotactic protocol,Submillimeter ISOTROPIC acquisition. Vertex to skull base. DICOM for surgical planning. Frame or fiducials if required,Position exactly as for surgery. Frame placement if required,Isotropic high-resolution for surgical targeting. Anatomic landmarks. Tumor if contrast,N/A (or 100mL if contrast),N/A (or 27s),N/A (or 40mL),N/A (or 11s),Head,Stereotactic scan,done (or crit if contrast),Variable,10s,N/A or verify eGFR,N/A or check allergy,Scout,Vertex,Skull base,N/A,N/A,Lateral,Stereotactic Head,Vertex,Skull base,N/A (or 60-90s if contrast),0.5-0.625 mm,Isotropic submillimeter,,,,,,,,,,,,,,,,,,,Axial,Stereo,Brain,0.5 mm/0.5 mm,Brain (Bone if needed),3,Isotropic axial,Coronal,Stereo,Brain,0.5 mm/0.5 mm,Brain,3,Isotropic coronal,Sagittal,Stereo,Brain,0.5 mm/0.5 mm,Brain,3,Isotropic sagittal midline,3D surface,Stereo,Brain,0.5 mm source,Brain,3,Surface for navigation,Isotropic voxels critical. Export DICOM to surgical planning,neuro,120,Auto (reference 300),Helical,Pitch for isotropic,Export to surgical navigation. Isotropic 0.5mm. Coordinates for targeting,
CT Orbits,2024-01-15,Dr. Davis,Orbital mass | Thyroid eye disease | Orbital cellulitis | Optic nerve assessment | Trauma,Supine head-first,NPO 2 hours if contrast,None,Omnipaque 350 if contrast,75-100 mL if contrast,3 mL/s,Non-contrast +/- contrast,N/A,N/A,Contrast if mass/infection. NC for trauma/foreign body,Orbits: superior orbital rim to maxillary sinus. Axial 1-2mm. Coronal reformats. NC for trauma. Contrast for masses/inflammation,Contrast for mass or inflammation. NC for trauma and metallic foreign body,Extraocular muscles. Optic nerve. Globe integrity. Orbital fat. Preseptal vs postseptal. Masses. Foreign body,90mL if contrast,25s,40mL,11s,Orbits,NC or contrast,done or crit,Variable,5s,N/A or verify eGFR > 30,N/A or check allergy,Scout,Superior orbital rim,Maxillary sinus,N/A,N/A,Lateral,Axial Orbits,Superior orbital rim,Maxillary sinus,N/A or 60s if contrast,1-1.5 mm,Parallel to optic nerves,,,,,,,,,,,,,,,,,,,Axial,Orbits,Orbits,1.5 mm/1 mm,Bone and Standard,3,Bone for fractures soft tissue for pathology,Coronal,Orbits,Orbits,1.5 mm/1 mm,Bone and Standard,3,Coronal orbits,Sagittal,Orbits,Optic nerve,2 mm/1.5 mm,Standard,3,Optic nerve canal,3D if trauma,Orbits,Orbital bones,1 mm source,Bone,N/A,3D if complex fracture,Angle axial parallel to optic nerves. Thin slices,neuro,120,Auto (reference 200-250),0.5,Helical,Assess optic nerve canal. Measure EOMs if thyroid eye disease. Document foreign body,
CT Temporal Bones,2024-01-15,Dr. Anderson,Hearing loss | Chronic otitis | Cholesteatoma | Temporal bone fracture | Pre-operative cochlear implant,Supine head-first,None,None,None,None,None,Non-contrast,N/A,N/A,No contrast. High resolution bone algorithm,Temporal bones: external auditory canal to petrous apex. SUBMILLIMETER <0.625mm. Direct axial and direct coronal if possible. Ultra high resolution,No IV. Remove hearing aids and earrings,Ossicles. Cochlea. Semicircular canals. Internal auditory canal. Mastoid air cells. Cholesteatoma. Fracture. Tegmen,N/A,N/A,N/A,N/A,Temporal bones,Non-contrast HR,done,0:00,8s,N/A,N/A,Scout,EAC level,Petrous apex,N/A,N/A,Lateral,Axial Temporal,EAC,Petrous apex,N/A,0.5-0.625 mm,Parallel to lateral SCC,Coronal Temporal,EAC,IAC,N/A,0.5-0.625 mm,Perpendicular to petrous ridge,,,,,,,,,,,,,Axial,Temporal,Bilateral,0.5 mm/0.5 mm,Bone sharp,N/A,Ultra HR bone,Coronal,Temporal,Bilateral,0.5 mm/0.5 mm,Bone sharp,N/A,Coronal bone,Oblique sagittal,Temporal,Ossicles,0.5 mm,Bone,N/A,Ossicular chain,Pschl/Stenvers,Temporal,IAC,0.75 mm,Bone,N/A,IAC oriented views,Submillimeter critical. Sharp bone kernel. Remove all metal,neuro,120,High mAs (300-400),Axial/Coronal,Sequential or helical,Pschl and Stenvers oblique reformats for IAC. Measure vestibular aqueduct,
CT Soft Tissue Neck,2024-01-15,Dr. Thompson,Neck mass | Deep neck infection | Abscess | Airway assessment | Lymphadenopathy,Supine head-first,NPO 2 hours,None,Omnipaque 350,100 mL,3 mL/s,Contrast with 60-70s delay,N/A,N/A,Full dose if eGFR > 30. Contrast essential,Skull base to thoracic inlet. 60-70 sec delay for venous phase. Arms down. Minimize swallowing. May need NC if calcium assessment,18-20G IV. Coach no swallowing during scan,Assess neck spaces. Retropharyngeal. Parapharyngeal. Masticator. Parotid. Submandibular. Thyroid. Lymph nodes. Abscess vs phlegmon,100mL,27s,40mL,11s,Neck,Venous phase,done,1:10,12s,Verify eGFR > 30,Check allergy history,Scout,Skull base,Thoracic inlet,N/A,N/A,Lateral,Contrast Neck,Skull base,Thoracic inlet,60-70 sec,1-2 mm,Venous phase,,,,,,,,,,,,,,,,,,,Axial,Neck,Neck,2.5 mm/2 mm,Standard,3,Soft tissue neck,Coronal,Neck,Neck,3 mm/2.5 mm,Standard,3,Coronal neck spaces,Sagittal,Neck,Midline,3 mm/2.5 mm,Standard,3,Airway and retropharyngeal,,,,,,,,Arms down. Minimize swallowing. Quiet breathing,neuro,120,Auto (reference 200-250),0.5,1,Assess all neck spaces. Measure lymph nodes. Airway diameter if concern,
CT Parathyroid 4D,2024-01-15,Dr. Kim,Hyperparathyroidism | Parathyroid adenoma localization | Pre-operative parathyroid planning,Supine head-first with arms down,NPO 4 hours,None,Omnipaque 350,75-100 mL,4 mL/s,4D multi-phase,Carotid artery,150 HU,Full dose if eGFR > 30,FOUR phases: 1) NC 2) Arterial 25s 3) Venous 55s 4) Delayed/washout 90s. Skull base to mediastinum. Parathyroid enhances early washes out,18-20G IV. High flow rate for arterial,NC: baseline. Arterial: parathyroid lights up. Venous: thyroid enhances. Delayed: parathyroid washes out faster than thyroid,90mL,20s,40mL,10s,Neck/Upper chest,Multi-phase 4D,crit,Variable,40s total,Verify eGFR > 30,Check allergy history,Scout,Skull base,Carina,N/A,N/A,AP lateral,Non-Contrast,Skull base,Carina,N/A,2.5 mm,Baseline,Arterial Phase,Skull base,Carina,25 sec,2 mm,Parathyroid enhancement,Venous Phase,Skull base,Carina,55 sec,2 mm,Thyroid enhancement,Delayed Phase,Skull base,Carina,90 sec,2.5 mm,Washout phase,Axial,All phases,Neck,2 mm/2 mm,Standard,3,Compare all four phases,Axial,Arterial,Neck,2 mm/2 mm,Standard,3,Peak parathyroid enhancement,Subtraction,Arterial - NC,Neck,2 mm,Standard,3,Enhance parathyroid conspicuity,Coronal,Arterial,Neck,2.5 mm,Standard,3,Ectopic adenoma search,Four phase critical. Look for early enhancement and washout,neuro,120,Auto (reference 200),0.5,1,Subtraction images. Compare all phases. Document location for surgeon. Measure size,
CT Cervical Spine,2024-01-15,Dr. Rodriguez,Cervical spine trauma | Degenerative disease | Neck pain | Radiculopathy | Myelopathy,Supine head-first,None,None,None typically. Contrast if infection/tumor,If contrast: 100 mL,3 mL/s,Non-contrast typically,N/A,N/A,NC typical. Contrast for infection tumor or post-op,Skull base to T1. Submillimeter helical. Sagittal and coronal reformats required. Bone algorithm,No IV unless contrast needed. Cervical precautions if trauma,Alignment. Fractures. Disc spaces. Neural foramina. Spinal canal. Facet joints. Degenerative changes,N/A or 100mL,N/A or 27s,N/A or 40mL,N/A or 11s,C-spine,NC or contrast scan,done,Variable,8s,N/A or verify eGFR,N/A or check allergy,Scout,Skull base,T1,N/A,N/A,AP and lateral,C-spine Helical,Skull base,T1,N/A or 60s if contrast,0.625 mm,Submillimeter acquisition,,,,,,,,,,,,,,,,,,,Axial,C-spine,C-spine,2 mm/2 mm,Bone,3,Bone and soft tissue,Sagittal,C-spine,C-spine,2 mm/1.5 mm,Bone,3,Midline and parasagittal,Coronal,C-spine,C-spine,2 mm/2 mm,Bone,3,Coronal alignment,Oblique sagittal,C-spine,Neural foramina,2 mm,Bone,3,Foraminal narrowing,Minimize motion. C-collar if trauma,neuro,120,Auto (reference 250),0.5,Helical,Sagittal and coronal bone reconstructions. Oblique for foramina,
CT Thoracic Spine,2024-01-15,Dr. White,Thoracic spine trauma | Compression fracture | Back pain | Tumor | Infection,Supine,None,None,None typically. Contrast if infection/tumor,If contrast: 100 mL,3 mL/s,Non-contrast typically,N/A,N/A,NC typical. Contrast for infection tumor mets,C7 to L1. Submillimeter helical. Sagittal and coronal reformats. Arms up if possible,No IV unless contrast indicated. Arms up to reduce artifact,Alignment. Compression fractures. Pedicles. Spinal canal. Disc spaces. Paraspinal soft tissues,N/A or 100mL,N/A or 27s,N/A or 40mL,N/A or 11s,T-spine,NC or contrast scan,done,Variable,10s,N/A or verify eGFR,N/A or check allergy,Scout,C7,L1,N/A,N/A,AP and lateral,T-spine Helical,C7,L1,N/A or 60s if contrast,0.625-1 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,T-spine,T-spine,2 mm/2 mm,Bone,3,Bone and soft tissue,Sagittal,T-spine,T-spine,2 mm/1.5 mm,Bone,3,Midline and parasagittal,Coronal,T-spine,T-spine,2.5 mm/2 mm,Bone,3,Coronal overview,,,,,,,,Arms up reduces artifact. Bone algorithm,neuro,120,Auto (reference 250),0.5,Helical,,
CT Lumbar Spine,2024-01-15,Dr. Hayes,Lumbar spine trauma | Degenerative disease | Back pain | Radiculopathy | Sciatica,Supine,None,None,None typically. Contrast if infection/tumor/post-op,If contrast: 100 mL,3 mL/s,Non-contrast typically,N/A,N/A,NC typical. Contrast for infection tumor or post-op with hardware,T12 to sacrum. Submillimeter helical. Sagittal and coronal reformats. Oblique for foramina,No IV unless contrast needed,Alignment. Fractures. Disc spaces. Spinal canal stenosis. Neural foramina. Facet joints. Spondylolisthesis,N/A or 100mL,N/A or 27s,N/A or 40mL,N/A or 11s,L-spine,NC or contrast scan,done,Variable,8s,N/A or verify eGFR,N/A or check allergy,Scout,T12,Sacrum,N/A,N/A,AP and lateral,L-spine Helical,T12,Sacrum,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,L-spine,L-spine,2 mm/2 mm,Bone,3,Bone and soft tissue,Sagittal,L-spine,L-spine,2 mm/1.5 mm,Bone,3,Midline and parasagittal,Coronal,L-spine,L-spine,2.5 mm/2 mm,Bone,3,Coronal overview,Oblique sagittal,L-spine,Neural foramina,2 mm,Bone,3,Foraminal assessment,Bone algorithm. Sagittal and coronal reconstructions,neuro,120,Auto (reference 250),0.5,Helical,Oblique sagittal for foramina. Measure spinal canal. Grade stenosis,
CT Complete Spine,2024-01-15,Dr. Chen,Spine trauma pan-scan | Multi-level disease | Metastatic survey | Infection,Supine,None - usually trauma,None,None typically. Contrast if infection/mets,If contrast: 125 mL,3 mL/s,Non-contrast typically,N/A,N/A,NC for trauma. Contrast for mets or infection,Skull base to sacrum. LONG COVERAGE. Submillimeter. Sagittal and coronal entire spine. May do in segments,No IV unless contrast needed. Complete spine coverage,Entire spine alignment. Fractures all levels. Spinal canal. Paraspinal masses. Metastatic disease,N/A or 125mL,N/A or 35s,N/A or 40mL,N/A or 11s,Complete spine,NC or contrast scan,done,Variable,25s,N/A or verify eGFR,N/A or check allergy,Scout,Skull base,Sacrum,N/A,N/A,Full AP and lateral,Complete Spine,Skull base,Sacrum,N/A or 60s if contrast,0.625-1 mm,Submillimeter entire spine,,,,,,,,,,,,,,,,,,,Axial,Spine,Full spine,2 mm/2 mm,Bone,3,Axial entire spine,Sagittal,Spine,Full spine,2 mm/1.5 mm,Bone,3,Sagittal full spine,Coronal,Spine,Full spine,2.5 mm/2 mm,Bone,3,Coronal full spine,,,,,,,,Long coverage. May need multiple acquisitions,neuro,120,Auto (reference 250),0.5,Helical,Sagittal and coronal bone reconstructions. Oblique for foramina,
CT Myelogram,2024-01-15,Dr. Martinez,Post-myelogram CT | Intrathecal contrast follow-up | Spinal stenosis | Nerve root compression,Supine. Post-lumbar puncture,None,Intrathecal contrast already given,Omnipaque 240 intrathecal,10-15 mL IT,N/A,Post-myelogram imaging,N/A,N/A,Intrathecal contrast given by clinician via LP,Post-LP CT. Usually lumbar region. Thin slices. Axial and sagittal reformats. Assess nerve root sleeves and thecal sac,Patient already had LP with IT contrast. Position comfortably,Nerve root sleeves. Thecal sac compression. Spinal stenosis. Disc herniations. Surgical planning detail,N/A,N/A,N/A,N/A,Spine,Post-myelogram,done,Variable,10s,N/A,N/A,Scout,Coverage area,Based on region,N/A,N/A,AP and lateral,CT Myelogram,Region of interest,Extended coverage,N/A,0.625 mm,Submillimeter for detail,,,,,,,,,,,,,,,,,,,Axial,Myelogram,Spine,1 mm/1 mm,Bone and Standard,3,Nerve roots and thecal sac,Sagittal,Myelogram,Spine,1.5 mm/1 mm,Standard,3,Thecal sac and compression,Coronal,Myelogram,Spine,2 mm/1.5 mm,Standard,3,Coronal nerve roots,Oblique sagittal,Myelogram,Neural foramina,1.5 mm,Standard,3,Foraminal nerve roots,Post-LP headache precautions. Thin slices for nerve detail,neuro,120,Auto (reference 250),0.5,Helical,Oblique reformats for nerve roots. Document stenosis level and severity,
MSK Protocol General,2024-01-15,Dr. Lee,Pre-operative planning | Post-operative assessment | Infection | Mass | Soft tissue tumor | Abscess,Depends on body part,NPO 2-4 hours if contrast,None,Omnipaque 350 if contrast,100 mL if contrast,2-3 mL/s,Non-contrast +/- contrast +/- delay,N/A,N/A,Contrast for infection mass post-op. NC for trauma hardware,Field of view specific to region. Submillimeter if 3D needed. NC and/or contrast based on indication. Delayed phase (5-10 min) for infection/tumor,IV for contrast studies. Document indication,NC: baseline bone soft tissue. Contrast: enhancement pattern. Delayed: washout or persistent enhancement. 3D for surgical planning,100mL if used,28s,40mL,11s,Variable MSK,Variable phases,Variable,Variable,Variable,N/A or eGFR > 30,N/A or check allergy,Scout,Region specific,Region specific,N/A,N/A,Two views,Non-contrast,Region,Region,N/A,0.625-1 mm,Baseline if done,Contrast phase,Region,Region,60-90 sec if done,0.625-1 mm,Standard if done,Delayed phase,Region,Region,5-10 min if done,1-2 mm,For infection/tumor,,,,,,,Axial,Acquisition,Region,1-2 mm/1-2 mm,Bone and Standard,3,Primary images,Coronal,Region,Region,2 mm/2 mm,Bone and Standard,3,Coronal reformats,Sagittal,Region,Region,2 mm/2 mm,Bone and Standard,3,Sagittal reformats,3D if needed,Region,Bones,0.625-1 mm source,Bone,N/A,3D for surgical planning,Tailor protocol to clinical question. Bilateral for comparison,msk,120,Auto (reference 200-250),0.5,Helical,Compare to contralateral side. Measure lesions. Bone and soft tissue windows,
CT Ankle,2024-01-15,Dr. Patel,Ankle fracture | Ligament injury | Pilon fracture | Pre-operative planning | Hardware assessment,Supine feet first,None,None,None typically. Contrast if infection/mass,If contrast: 75 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection or soft tissue mass,Include distal tibia/fibula through hindfoot. Submillimeter for 3D. Bilateral scout for positioning. May scan bilateral for comparison,No IV unless contrast needed,Malleolar fractures. Tibial plafond. Talus. Calcaneus. Syndesmosis. Ligaments on contrast,N/A or 75mL,N/A or 21s,N/A or 30mL,N/A or 8s,Ankle,NC or contrast,done,Variable,5s,N/A or eGFR > 30,N/A or check allergy,Scout Bilateral,Bilateral ankles,Feet,N/A,N/A,AP for positioning,CT Ankle,Distal tib/fib,Hindfoot,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Ankle,Ankle,1 mm/1 mm,Bone,N/A,Bone algorithm,Coronal,Ankle,Ankle,1.5 mm/1 mm,Bone,N/A,Coronal ankle,Sagittal,Ankle,Ankle,1.5 mm/1 mm,Bone,N/A,Sagittal ankle,3D surface,Ankle,Bones,0.625 mm source,Bone,N/A,3D for complex fractures,Bilateral scout for symmetry. Submillimeter for 3D,msk,120,Auto (reference 200),0.5,Helical,3D reconstruction for surgical planning. Document fracture fragments,
CT Foot,2024-01-15,Dr. Davis,Foot fracture | Lisfranc injury | Tarsal fractures | Foreign body | Pre-operative planning,Supine feet first,None,None,None typically. Contrast if infection,If contrast: 75 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma foreign body. Contrast for infection osteomyelitis,Calcaneus through toes. Submillimeter. Weight-bearing position if able. Bilateral for comparison,No IV unless infection suspected,Calcaneus. Talus. Navicular. Cuneiforms. Metatarsals. Phalanges. Lisfranc ligament. Plantar fascia,N/A or 75mL,N/A or 21s,N/A or 30mL,N/A or 8s,Foot,NC or contrast,done,Variable,5s,N/A or eGFR > 30,N/A or check allergy,Scout,Calcaneus,Toes,N/A,N/A,Lateral and AP,CT Foot,Calcaneus,Toes,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Foot,Foot,1 mm/1 mm,Bone,N/A,Axial bone,Coronal,Foot,Foot,1.5 mm/1 mm,Bone,N/A,Coronal foot,Sagittal,Foot,Foot,1.5 mm/1 mm,Bone,N/A,Sagittal foot,Oblique,Foot,Lisfranc,1.5 mm,Bone,N/A,Lisfranc joint,Weight-bearing if possible. Bilateral comparison helpful,msk,120,Auto (reference 200),0.5,Helical,Document Lisfranc alignment. Calcaneal angles. 3D if complex,
CT Gout Protocol,2024-01-15,Dr. Johnson,Gout | Tophi | Urate deposition | CPPD | Crystal arthropathy,Variable - affected joint,None,None,None,None,None,Non-contrast dual energy,N/A,N/A,No contrast. Dual energy CT preferred,Dual energy CT if available for urate detection. Single energy if not. Cover affected joint(s). Extended FOV if polyarticular,No IV. Document affected joints,Urate crystals color-coded on DECT. Tophi. Joint erosions. Soft tissue deposits. Quantify urate burden,N/A,N/A,N/A,N/A,Joint(s),DECT preferred,done,0:00,Variable,N/A,N/A,Scout,Joint region,Extended as needed,N/A,N/A,Appropriate views,DECT or CT,Joint region,Extended coverage,N/A,0.625-1 mm,Dual energy if available,,,,,,,,,,,,,,,,,,,Axial,Gout,Joints,1 mm/1 mm,Bone and Standard,3,Standard images,DECT urate,Gout,Joints,Color overlay,Urate algorithm,N/A,Urate crystal map,3D volume,Gout,Urate burden,Volumetric,Urate,N/A,Quantify total urate,Coronal,Gout,Joints,1.5 mm,Bone,N/A,Joint erosions,Dual energy preferred for urate detection,msk,Dual energy 80/140Sn or equivalent,Auto,0.5,Helical,Urate volume quantification. Color overlay. Document tophi locations,
CT Knee,2024-01-15,Dr. Thompson,Knee fracture | Tibial plateau | Patellar fracture | Pre-operative planning | Hardware evaluation,Supine feet first,None,None,None typically. Contrast if infection/mass,If contrast: 75 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection or tumor,Distal femur through proximal tibia/fibula. Submillimeter. Extended FOV for alignment. Bilateral scout,No IV unless contrast indicated,Tibial plateau fractures (Schatzker). Femoral condyles. Patella. Fibula. Cruciate ligaments on contrast. Menisci,N/A or 75mL,N/A or 21s,N/A or 30mL,N/A or 8s,Knee,NC or contrast,done,Variable,8s,N/A or eGFR > 30,N/A or check allergy,Scout Bilateral,Bilateral knees,Extended,N/A,N/A,AP for alignment,CT Knee,Distal femur,Proximal tib/fib,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Knee,Knee,1.5 mm/1 mm,Bone,N/A,Bone algorithm,Coronal,Knee,Knee,1.5 mm/1 mm,Bone,N/A,Coronal knee,Sagittal,Knee,Knee,1.5 mm/1 mm,Bone,N/A,Sagittal knee,3D surface,Knee,Bones,0.625 mm source,Bone,N/A,3D for surgical planning,Bilateral scout for alignment assessment,msk,120,Auto (reference 200),0.5,Helical,Schatzker classification if tibial plateau. Measure alignment. 3D reconstruction,
CT Upper Extremity,2024-01-15,Dr. White,Upper extremity fracture | Humerus | Radius/ulna | Forearm | Elbow injury,Supine with arm positioned,None,None,None typically. Contrast if infection,If contrast: 75 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection or soft tissue mass,FOV based on region: shoulder to hand. Submillimeter for fracture detail. Position for comfort and coverage,No IV unless contrast needed,Fractures. Alignment. Intra-articular extension. Comminution. Soft tissue injury on contrast,N/A or 75mL,N/A or 21s,N/A or 30mL,N/A or 8s,Upper extremity,NC or contrast,done,Variable,Variable,N/A or eGFR > 30,N/A or check allergy,Scout,Region specific,Extended,N/A,N/A,AP and lateral,CT Upper Extremity,Proximal to injury,Distal to injury,N/A or 60s if contrast,0.625-1 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Upper extremity,Region,1-2 mm/1-2 mm,Bone,N/A,Bone windows,Coronal,Upper extremity,Region,2 mm/2 mm,Bone,N/A,Coronal,Sagittal,Upper extremity,Region,2 mm/2 mm,Bone,N/A,Sagittal,3D surface,Upper extremity,Bones,0.625 mm source,Bone,N/A,3D if complex,Position for patient comfort and diagnostic quality,msk,120,Auto (reference 200),0.5,Helical,Document fracture location alignment. Soft tissue windows if contrast,
CT Lower Extremity,2024-01-15,Dr. Rodriguez,Lower extremity fracture | Tibia/fibula | Femur | Post-operative hardware assessment,Supine,None,None,None typically. Contrast if infection,If contrast: 100 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection osteomyelitis,FOV based on region: hip to ankle. Submillimeter for fracture. Extended coverage for alignment,No IV unless contrast needed,Fractures. Alignment. Comminution. Intra-articular extension. Hardware position. Infection on contrast,N/A or 100mL,N/A or 28s,N/A or 40mL,N/A or 11s,Lower extremity,NC or contrast,done,Variable,Variable,N/A or eGFR > 30,N/A or check allergy,Scout,Region specific,Extended,N/A,N/A,AP and lateral,CT Lower Extremity,Proximal to injury,Distal to injury,N/A or 60s if contrast,0.625-1 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Lower extremity,Region,2 mm/2 mm,Bone,N/A,Bone windows,Coronal,Lower extremity,Region,2 mm/2 mm,Bone,N/A,Coronal,Sagittal,Lower extremity,Region,2 mm/2 mm,Bone,N/A,Sagittal,3D surface,Lower extremity,Bones,0.625 mm source,Bone,N/A,3D reconstruction,Extended coverage for alignment measurements,msk,120,Auto (reference 200-250),0.5,Helical,Alignment measurements. Hardware position. 3D for surgical planning,
CT Hip,2024-01-15,Dr. Anderson,Hip fracture | Acetabular fracture | Femoral neck | Pre-operative planning | FAI assessment,Supine,None,None,None typically. Contrast if infection/mass,If contrast: 100 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection AVN or tumor,Iliac crests through proximal femurs. Bilateral for comparison. Submillimeter for 3D acetabular reconstructions,No IV unless contrast indicated,Femoral neck fractures. Acetabular fractures (Judet/Letournel). Hip dislocation. FAI morphology. AVN,N/A or 100mL,N/A or 28s,N/A or 40mL,N/A or 11s,Hip/Pelvis,NC or contrast,done,Variable,10s,N/A or eGFR > 30,N/A or check allergy,Scout,Iliac crests,Proximal femurs,N/A,N/A,AP,CT Pelvis/Hips,Iliac crests,Proximal femurs,N/A or 60s if contrast,0.625 mm,Submillimeter for 3D,,,,,,,,,,,,,,,,,,,Axial,Hips,Pelvis/hips,2 mm/2 mm,Bone,N/A,Axial bone,Coronal,Hips,Pelvis/hips,2 mm/2 mm,Bone,N/A,Coronal hips,Sagittal,Hips,Each hip,2 mm/2 mm,Bone,N/A,Sagittal hips,Judet views,Hips,Acetabulum,2 mm oblique,Bone,N/A,Obturator and iliac obliques,Bilateral coverage. Submillimeter for acetabular 3D,msk,120,Auto (reference 250),0.5,Helical,3D pelvis. Judet oblique views. Letournel classification. FAI measurements (alpha angle),
CT Pelvis MSK,2024-01-15,Dr. Kim,Pelvic fracture | Sacral fracture | SI joint | Pelvic ring injury | Pre-operative planning,Supine,None,None,None typically. Contrast if infection,If contrast: 100 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection or tumor,Iliac crests to proximal femurs. Submillimeter for 3D. Assess pelvic ring integrity. Inlet and outlet views,No IV unless contrast indicated,Pelvic ring fractures (Young-Burgess). Sacral fractures (Denis). Acetabulum. SI joints. Symphysis pubis,N/A or 100mL,N/A or 28s,N/A or 40mL,N/A or 11s,Pelvis,NC or contrast,done,Variable,12s,N/A or eGFR > 30,N/A or check allergy,Scout,Iliac crests,Proximal femurs,N/A,N/A,AP,CT Pelvis,Iliac crests,Proximal femurs,N/A or 60s if contrast,0.625 mm,Submillimeter for 3D,,,,,,,,,,,,,,,,,,,Axial,Pelvis,Pelvis,2 mm/2 mm,Bone,N/A,Axial bone,Coronal,Pelvis,Pelvis,2 mm/2 mm,Bone,N/A,Coronal pelvis,Sagittal,Pelvis,Pelvis,2 mm/2 mm,Bone,N/A,Sagittal sacrum,Inlet/Outlet,Pelvis,Pelvic ring,2-3 mm oblique,Bone,N/A,Pelvic ring views,Submillimeter for 3D pelvic reconstruction,msk,120,Auto (reference 250),0.5,Helical,3D pelvis. Inlet and outlet views. Young-Burgess classification. Measure displacement,
CT Hand,2024-01-15,Dr. Chen,Hand fracture | Scaphoid fracture | Metacarpal fracture | Foreign body | Pre-operative planning,Prone with hand extended (superman position) or supine with arm at side,None,None,None typically. Contrast if infection,If contrast: 50 mL,2 mL/s,Non-contrast typical,N/A,N/A,NC for trauma foreign body. Contrast for infection,Distal radius/ulna through fingertips. Submillimeter. Position hand flat. Bilateral scout for comparison,No IV unless infection suspected,Carpal fractures (scaphoid navicular lunate). Metacarpals. Phalanges. CMC joints. Foreign bodies,N/A or 50mL,N/A or 18s,N/A or 30mL,N/A or 8s,Hand,NC or contrast,done,Variable,5s,N/A or eGFR > 30,N/A or check allergy,Scout,Distal radius/ulna,Fingertips,N/A,N/A,AP and lateral,CT Hand,Distal radius/ulna,Fingertips,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Hand,Hand,1 mm/0.75 mm,Bone,N/A,Thin axial,Coronal,Hand,Hand,1 mm/0.75 mm,Bone,N/A,Coronal hand,Sagittal,Hand,Hand,1 mm/0.75 mm,Bone,N/A,Sagittal hand,Oblique sagittal,Hand,Scaphoid,1 mm,Bone,N/A,Scaphoid long axis,Superman position preferred. Submillimeter for scaphoid,msk,120,Auto (reference 150-200),0.5,Helical,Scaphoid-specific views. 3D if complex. Document foreign body location,
CT Wrist,2024-01-15,Dr. Hayes,Wrist fracture | Distal radius fracture | Carpal fracture | DRUJ | Scapholunate ligament,Prone with wrist extended (superman) or positioned for comfort,None,None,None typically. Contrast if infection,If contrast: 50 mL,2 mL/s,Non-contrast typical. Arthrogram contrast if ligament assessment,N/A,N/A,NC for fracture. Arthrogram for ligament,Distal radius/ulna through carpus. Submillimeter for carpal detail. Extended for forearm if needed,No IV unless contrast or arthrogram needed,Distal radius fractures. Carpal fractures (scaphoid). DRUJ. Carpal alignment. Ligaments on arthrogram,N/A or 50mL,N/A or 18s,N/A or 30mL,N/A or 8s,Wrist,NC or arthrogram,done,Variable,5s,N/A or eGFR > 30,N/A or check allergy,Scout,Distal forearm,Carpus,N/A,N/A,AP lateral,CT Wrist,Distal radius/ulna,Mid-carpus,N/A or immediate if arthrogram,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Wrist,Wrist,1 mm/0.75 mm,Bone,N/A,Axial bone,Coronal,Wrist,Wrist,1 mm/0.75 mm,Bone,N/A,Coronal wrist,Sagittal,Wrist,Wrist,1 mm/0.75 mm,Bone,N/A,Sagittal wrist,Oblique sagittal,Wrist,Scaphoid,1 mm,Bone,N/A,Scaphoid long axis,Position for comfort. Submillimeter for carpal bones,msk,120,Auto (reference 150-200),0.5,Helical,Scaphoid views. Carpal alignment. 3D if complex fracture,
CT Elbow,2024-01-15,Dr. Martinez,Elbow fracture | Radial head fracture | Olecranon fracture | Coronoid | Terrible triad,Supine with elbow extended if possible or positioned for comfort,None,None,None typically. Contrast if infection,If contrast: 75 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection or soft tissue mass,Distal humerus through proximal radius/ulna. Submillimeter. Position extended if possible. Bilateral for comparison,No IV unless contrast needed,Distal humerus fractures. Radial head. Olecranon. Coronoid. Elbow dislocation. Terrible triad,N/A or 75mL,N/A or 21s,N/A or 30mL,N/A or 8s,Elbow,NC or contrast,done,Variable,5s,N/A or eGFR > 30,N/A or check allergy,Scout,Distal humerus,Proximal forearm,N/A,N/A,AP lateral,CT Elbow,Distal humerus,Proximal radius/ulna,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Elbow,Elbow,1.5 mm/1 mm,Bone,N/A,Axial bone,Coronal,Elbow,Elbow,1.5 mm/1 mm,Bone,N/A,Coronal elbow,Sagittal,Elbow,Elbow,1.5 mm/1 mm,Bone,N/A,Sagittal elbow,3D surface,Elbow,Bones,0.625 mm source,Bone,N/A,3D for complex fractures,Position extended if possible. Submillimeter for detail,msk,120,Auto (reference 200),0.5,Helical,Document terrible triad if present. Radial head-capitellum alignment. 3D reconstruction,
CT Shoulder,2024-01-15,Dr. Lee,Shoulder fracture | Proximal humerus | Glenoid | Scapula | Rotator cuff calcification,Supine with arm at side,None,None,None typically. Contrast if infection/mass,If contrast: 75 mL,2-3 mL/s,Non-contrast typical,N/A,N/A,NC for trauma. Contrast for infection or tumor,Include entire scapula and proximal humerus. Submillimeter for glenoid detail. Y-views for scapula,No IV unless contrast indicated,Proximal humerus fractures (Neer). Glenoid fractures. Scapular fractures. AC joint. Rotator cuff calcifications,N/A or 75mL,N/A or 21s,N/A or 30mL,N/A or 8s,Shoulder,NC or contrast,done,Variable,8s,N/A or eGFR > 30,N/A or check allergy,Scout,Include scapula,Proximal humerus,N/A,N/A,AP and Y-view,CT Shoulder,Entire scapula,Proximal humerus,N/A or 60s if contrast,0.625 mm,Submillimeter,,,,,,,,,,,,,,,,,,,Axial,Shoulder,Shoulder,1.5 mm/1 mm,Bone,N/A,Axial bone,Coronal,Shoulder,Shoulder,2 mm/1.5 mm,Bone,N/A,Coronal shoulder,Sagittal,Shoulder,Shoulder,2 mm/1.5 mm,Bone,N/A,Sagittal shoulder,Oblique,Shoulder,Glenoid,1.5 mm,Bone,N/A,Glenoid en face,Include entire scapula. Submillimeter for glenoid,msk,120,Auto (reference 200),0.5,Helical,3D reconstruction. Neer classification if proximal humerus. Glenoid version measurements,
CT Arthrogram Shoulder,2024-01-15,Dr. Patel,Labral tear | Rotator cuff tear | Capsular injury | Shoulder instability,Supine with arm at side,None,Intra-articular contrast injection by radiologist,Omnipaque 240 or 300 diluted,12-15 mL intra-articular,N/A,Post-arthrogram,N/A,N/A,Arthrogram contrast injected under fluoro or US,Post-arthrogram CT. Inject glenohumeral joint. Immediate CT after injection. Thin slices for labrum,Radiologist performs injection. Patient to CT immediately after,Labral tears. Rotator cuff tears. Capsular tears. Glenohumeral ligaments. Paralabral cysts,N/A,N/A,N/A,N/A,Shoulder,Post-arthrogram,done,Immediate,5s,N/A,Contrast reaction history,Scout,Shoulder region,Proximal humerus,N/A,N/A,AP,CT Arthrogram,Acromion,Proximal humerus,Immediate post-injection,0.625 mm,Submillimeter for labrum,,,,,,,,,,,,,,,,,,,Axial,Arthrogram,Shoulder,1 mm/0.75 mm,Standard,3,Thin for labral detail,Coronal,Arthrogram,Shoulder,1.5 mm/1 mm,Standard,3,Coronal oblique shoulder,Sagittal,Arthrogram,Shoulder,1.5 mm/1 mm,Standard,3,Sagittal oblique,Abduction ABER,Arthrogram,Shoulder,1.5 mm,Standard,3,ABER position if done,Scan immediately after injection. Thin slices for labrum,msk,120,Auto (reference 150-200),0.5,Helical,Oblique coronal and sagittal. Assess labrum rotator cuff capsule. Document contrast extravasation,